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Abstract
An excessive accumulation of the cerebrospinal fluid (CSF) in the ventricles of the 
brain results in hydrocephalus, a condition that without treatment may lead to 
brain damage. The common remedy is a procedure whereby a shunt is implanted 
into the ventricles of the brain to drain the excess fluid to another part of the 
body, controlled by a pressure dependent valve, which opens when the CSF pres­
sure exceeds a preset opening threshold.
As intracranial pressure (ICP) is critical for hydrocephalus patients, improper 
shunt functionality will either lead to underdrainage which leaves ICP high caus­
ing brain damage or overdrain the CSF breaking the ICP balance, and in both 
cases it is fatal for the patient, this is in the short run. While the normal ab­
sorption paths still functioning to a certain limit in most cases of hydrocephalus, 
the current shunting technique causes the normal drainage system to rely on the 
artificial drainage systems and does not let the skull and the absorption system 
to accommodate properly to the CSF being produced, this is in the long run. So 
it is important that the shunt could respond dynamically and intelligently accom­
modate itself to the patient in-specific needs. Unfortunately and despite shunts 
being standard treatment for over 40 years, these shunts still passive and depends 
on difl’erential pressure as a valve regulating parameter which is subject to many 
affecting aspects.
This thesis proposes an intelligent shunting system (intelligent shunt) which grad­
ually deliberates and controls the opening pressure of the valve. The goal of such 
shunting technique is to keep the ICP within normal levels, while at the same time 
stimulate the normal pathways of absorption. If it is clear that shunt dependency 
is unavoidable then this intelligent shunt can optimise shunt parameters for pa­
tient’s needs.
This shunt technique is developed based on an intelligent agent system, this system 
mainly consists of two subsystems, the first subsystem is to manage the current 
situation of the ICP on the short run and to keep it within normal ranges un­
der certain conditions and restrictions, and the second subsystem is to pursue a 
weaning plan on the long run, in this subsystem and based on the original Actor- 
Critic method, a modified method of reinforcement learning is proposed and this 
method uses a Simulink model of ICP dynamics that personalise and optimise 
model’s parameters according to specific patient’s data by learning from his ICP
i
traces, which is used to estimate the CSF production and absorption volumes. 
Therefore, it is hypothesised that this approach will lead to a novel shunting tech­
nique that could accurately use an intelligent agent to optimise parameters of ICP 
dynamics model and then use it to satisfy the patient while evaluating shunt de­
pendency and treatment plans compliance.
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Chapter 1
Introduction
“With the right investment and RD, personalised healthcare has the potential to be 
the most significant development in medicine for years [1]”. Personalised health­
care nowadays is one of the most important areas of the intelligent technology, as it 
affects directly people’s quality of life [2]. “Intelligent agent technology has become 
a leading area of research in AI and computer science and the focus of a number 
of major initiatives [3]”. These intelligent agents are normally perceive patients’ 
status and knowledge base, and help expert making decision and choosing action, 
and then execute that action on the environment. Many healthcare applications 
benefit from such agent based systems, such as decision supporting system in diag­
nosis assistance, treatment recommending system, patient’s history and database 
examination system, and intensive care unit supporting and monitoring system.
In this work, the prime objective is to provide a personalised healthcare solution 
for hydrocephalus through optimising the functionality of the shunting system 
by using an intelligent agent. This system exhibits agent’s characteristics like
autonomy to operate without intervention from human, reactivity to respond to
1
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the perceived changes in the environment, proactiveness to take the initiative when 
appropriate.
1.1 Overview
The human brain is surrounded by a watery liquid produced in the parenchyma 
called cerebrospinal fluid (CSF). This both protects the brain from head injury 
and acts as a medium for tissue moisturising and transportation of the metabolism 
products. An excessive accumulation of this fluid inside the skull due to imbalance 
of absorption and production leads to a medical condition called hydrocephalus, 
and if left untreated can have fatal consequences. This imbalance in the CSF vol­
umes is often caused by problems in the drainage process in the normal pathways. 
Untreated, this imbalance leads to an elevation of the intracranial pressure (ICP) 
which has an effect on the brain and can be life-threatening [4].
The dominant treatment for hydrocephalus is to divert the CSF from the ventricles 
in the brain to another part of the body by means of an implanted shunt regulated 
by a valve [5], as shown in Figure 1.1.
Several studies have verified serious problems and shortcomings relating to current 
shunting techniques, such as incorrect drainage including both under-drainage 
where insufficient CSF drained is from the ventricles which keeps the ICP high 
and hence hydrocephalus symptoms are maintained, or over-drainage where high 
volume of CSF is drained more than required which breaks the CSF absorption 
and production balance causing bleeding [6]. These drawbacks and improper shunt 
settings such as valve opening pressure and flow resistance, reflect the inefficiency
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and inability of these shunts to autonomously respond to the hydrodynamics of 
CSF.
Central Part 
of Loft Lateral 
Ventricle
Right Lateral 
Ventricle
Choroid
Plexus
Central Canal
Figure 1.1: The ventricular system of the human brain [7] .
The latest advances in valve technology allow non-invasive adjustment of the pres­
sure settings. However, the current criteria for selection of the valve opening pres­
sures are not well-defined and are still far from efficient and not patient-specific. 
That is because the rate of CSF production and the pressure-flow relation are not 
precisely known in individual patients [8]. This leads to a high rate of shunt failure 
and multiple shunt revision, where 30% to 40% of shunts implanted in pediatric 
patients fail within the first year [9, 10, 11, 12].
Attempts to tackle these current shunts drawbacks are pursued by Miethke in 
his development of a mechatronic valve [13]. The value of such valve arises 
from its ability to be controlled in a different way based on a time schedule [14] 
rather than regulated by the differential pressure across the valve or the CSF flow 
rate. This development in shunt functionality provides the tool for new shunting 
system and treatment approaches. However, what is still challenging to this valve 
is the appropriate time schedule that would suit each patient and evaluating shunt 
dependency, which emphasizes the “personalised” aspect of this approach.
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Another aspect of current shunt drawbacks is shunt dependency. While the nor­
mal absorption paths are still functioning to a certain extent in most cases of 
hydrocephalus, the current shunting technique causes the body to become reliant 
on the artificial drainage system. This does not allow the skull and the absorption 
system to accommodate properly to the CSF being produced. It is reported that 
it is unnecessary to remove more than one-third of the produced CSF volume a 
day [6, 15]. Hence there is part of the CSF which is normally drained through the 
normal absorption system. This puts the need for the next generation of shunts to 
be able to evaluate the patient’s shunt dependency and gradually wean the patient 
off the shunt.
Few attempts of shunt removal were carried out [16, 17], which depend on rough 
estimation and anticipation of certain parameters. These attempts are referred to 
as non sufficient criteria for shunt independence evaluation and arresting. These 
attempts need long time monitoring during and after the treatment period, which 
could be extended to years. Adding to that it does not take the specific needs 
for each patient into consideration. Takahashi [16] used a programmable valve to 
arrest hydrocephalus by gradual changing of the valve opening pressure and he 
tried to activate the regular circulation of the CSF. His study showed the possi­
bility of removing the shunt system in 50% or more of hydrocephalus cases. His 
technique depends mainly on increasing the pressure in steps and for a certain 
periods and evaluating progress depending on the monitoring of the CT images. 
Takahashi noticed three types of cases: First type where ventricles remained the 
same size without symptoms, and in which most of the shunt removal were suc­
cessful. Second type, ventricles became large without symptoms, where some of 
the cases had successful shunt removal. Third type, enlargement in ventricle size 
had been noticed with clear symptoms where it is impossible to remove the shunt.
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Another study was carried out by Longatti and Carter! [17], they used a telemetric 
ICP measurement device and a multipurpose valve to investigate the possibility 
of shunt removal. They proposed the ICP as an indicator of individual conditions 
such as the residual pathways of CSF, ventricular size, and compliance of the sys­
tem. Based on the ICP level and the symptoms, they classified the compliances 
of the patients CSF circulation system after controlling the valve opening period, 
where four types of ICP trends were observed after closure of the programmable 
valve: First type exhibited early intracranial hypertension immediately after valve 
closure. Second type also exhibited intracranial hypertension but within longer 
period. Third type, ICP rose and stabilised at a range 20-40 cmi^O without any 
symptoms. Fourth type, the ICP remained without any change. As reported in 
their study, the first and second type were strictly shunt dependant, but the third 
and fourth types were not sufficient criteria for shunt independency. Even these 
techniques achieved good results, however they had disadvantages such as impre­
cise pressure setting, and can not operate with high pressure, long time monitoring 
during and after the treatment period is required, which could be extended to two 
or more year, and it lacks the precise understanding of the needs for each patients.
Hydrocephalus is diagnosed by clinical symptoms, like dementia, urinary incon­
tinence, and gait disturbance, and analysis of neuroimaging either by computer 
tomography (CT) or magnetic resonance imaging (MRI) coupled with mean value 
of ICP [18, 19, 20]. However, the ICP waveform proves to carry a lot of useful in­
formation and the data acquired from waveform recording are valuable to extract 
relevant information about the state of the patient [18]. On the other hand, these 
data sets are large and complex. Physicians, biomedical engineers, and surgeons 
are limited in the extent to which they can draw meaningful interpretations from 
visual inspection of this complex waveform. Other parameters derived from the
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raw ICP waveform are expected to offer additional insight into the nature of the 
underlying condition and the patients’ response to treatment.
An off-line optimiser system of the shunt settigns [21], as proposed in this thesis, 
would provide a personalised shunting system specific to each patient by proposing 
an optimal valve settings. These settings are opening pressure and flow resistance 
in differential pressure valve and optimal time schedule in time based valve. Inte­
grating this optimiser in the shunting system and enforced with a machine learning 
algorithm would provide autonomous management of hydrocephalus which also 
could lead to reducing shunt dependency based on the patient’s status [22].
1.2 Scope of Work
When differential pressure shunts were developed which apparently change favourably 
the treatment of hydrocephalus, then it becomes of great importance to overcome 
the drawbacks of such shunts. With the gradually rising use of various shunts 
in the treatment of hydrocephalus and with several problems and drawbacks of 
these shunts, upgrading these shunts has understandably become a necessity. This 
motivates the research in this fertile area in various aspects, from understanding 
the CSF dynamics and its relation to clinical outcome, to proper settings to the 
current shunt, then to a new generation of shunting techniques.
This work starts by presenting a multivariate analysis method based on a suggested 
set of extracted features from the ICP waveform, This allows the representation 
of time varying data which utilises Principal Component Analysis (PCA) that 
can assist in the interpretation of this data. Such analysis method provides an
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enhanced and less subjective approach to the traditional methods for diagnosing 
neurological disorders and hydrocephalus in particular.
As differential shunts are still the dominant treatment for hydrocephalus, different 
parameters that characterise shunt behaviour were analysed and investigated to 
assist in understanding their effect on the CSF dynamics. Consequently, a shunt 
optimiser was developed for utilising these parameters that would facilitate the 
method of proposing optimal shunt settings for each patient. Such an optimiser 
would be a valuable tool for the surgeon, leading to less shunt revisions and hos­
pitalisation periods.
A similar optimiser was developed and applied to the new shunting technique em­
ploying time-schedule based valve, where the ICP signal and CSF dynamics were 
investigated to understand the effect of the time-schedule on the valve behaviour, 
then the optimiser concludes an optimum schedule that can suit each patient. 
This development can provide a precise technique for evaluating the efficiency of 
this type of shunting, and an easy system that the surgeon can use to propose a 
suitable schedule for each patient.
As current shunting systems and treatments lack personalisation, a new approach 
in ICP dynamics modeling was adopted and developed for hydrocephalus to im­
prove diagnosis and treatment. This approach is to develop and utilise patient 
specific ICP model that can learn from patient’s ICP traces to optimise CSF dy­
namics parameters. After parameter optimisation, this model can be queried to 
evaluate ICP response to a specific shunting technique. Different shunt models 
were developed to be used in conjunction with the ICP model.
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After evaluating the current and the new shunting techniques, this research pro­
poses a new shunting technique; a personalised intelligent shunt. This shunt con­
figures a machine learning technique based on agent technology and incorporating 
the developed ICP model with sensory input for ICP readings. This intelligent 
shunt has the capability to adapt itself to the patient status by optimising the 
model parameters. Then, using a self-learning algorithm it manages and treats 
the patient in the short term by managing the ICP level (o remove symptoms) 
and in the long term by evaluating the patient’s shunt dependency, and initiating 
a weaning program. If it is clear that shunt dependency is unavoidable, then this 
intelligent shunt can optimise shunt settings for patient’s needs. A Figure of Merit 
(FoM) is developed to evaluate the patient’s progress in the short or long terms.
1.3 Contributions
The main original contributions of this research can be summarised as follows.
1. This work introduces a new analysis method for hydrocephalus patients’ 
data, by proposing a set of extracted features and a multivariate representa­
tion method. This method used to conclude trends from hydrocephalus data 
and find relation between different parameters, which could be used to diag­
nose and follow up patients’ outcome. These features and the multivariate 
method is first to be applied to this field.
2. Proposing a novel system for evaluating current shunt’s (differential-pressure 
shunt) efficiency, and using it as a surgeon tool for proposing proper shunt
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settings that suit each patient. A similar novel system is also proposed for 
evaluating proposed new shunt’s (time-based shunt) efficiency, and using it 
also as a tool for optimising a shunt time schedule for each patient.
3. Introducing a new approach in ICP modeling that could optimise its param­
eters to reflect patients status learning from its ICP data and then queried 
to find the response to a specific shunting technique.
4. Proposing a new FoM either for evaluating shunt performance or treatment 
efficiency. This FoM depends on vital parameters close to the hydrocephalus, 
such as CSF absorption and production.
5. Presenting and implementing an innovative shunting approach which could 
overcome most of the drawback of the current shunts. That in an au­
tonomous way can adapt itself to the current patient needs, and gradually 
evaluate shunt dependency and instantiate a weaning program according to 
that.
1.4 Published Work
Some of the results of this work have been published and presented in an interna­
tional conferences in this field, as listed below:
1. N. Al-Zubi, A. Alkharabsheh, L. Momani, and W. Al-Nuaimy. Intelligent 
Shunt Agent for Gradual Shunt removal, in Proceedings of the IEEE Eng 
Med Biol Soc. (EMBC2010), Buenos Aires, Argentina, pp. 430-433, Sep
2010.
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2. N. Al-Zubi, L. Momani, A. Alkharabsheh, and W. Al-Nnaimy. Multivariate 
Analysis of Intracranial Pressure (ICP) Signal Using Principal Component 
Analysis, in Proceedings of the IEEE Eng Med Biol Soc. (EMBC2009), 
Minnesota, USA, pp. 4670-4673, Sep 2009.
3. N. Al-Zubi, A. Alkharabsheh, L. Momani and W. Al-Nuaimy. Distributed 
Multi-agent Approach for Hydrocephalus treatment and management Using 
Electronic Shunting, in HEALTHINF2009, Porto, Portugal, pp. 503-507, 
Jan 2009.
4. N. Al-Zubi, L. Momani, A. Alkharabsheh and W. Al-Nuaimy. Treatment 
and Management Methodology of Hydrocephalus: Application of Electronic 
Shunt Multiagent System (eShunt), in Second International Conference on 
Developments in eSystems Engineering (DESE), Abu Dhabi, UAE, pp. 147- 
150, Dec 2009.
5. N. Al-Zubi, A. Al-kharabsheh, L. Momani and W. Al-Nuaimy. Personalised 
Hydrocephalus Shunt Settings Optimiser, 1st International Conference on 
Applied Bionics and Biomechanics (ICABB-2010), Venice, Italy, Oct 2010.
6. N. Al-Zubi, W. Al-Nuaimy and M. Al-Hadidi. Personalised Mechatronic 
Valve Time-Schedule Optimiser for Hydrocephalus Shunt, in 1st Middle East 
Conference on Biomedical Engineering (MECBME-2011), Sharjah, UAE, 
Feb 2011.
Contributions to other published manuscripts as a part of the research group work
are listed below:
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1. A. Alkharabsheh, L. Momani, N. Al-Zubi, and W. Al-Nuaimy. An Expert 
System for Hydrocephalus Patient Feedback, in Conf Proc IEEE Eng Med 
Biol Soc. (EMBC2010), Buenos Aires, Argentina, pp. 1166-1169, Sep 2010.
2. L. Momani, A. Alkharabsheh, N. Al-Zubi, and W. Al-Nuaimy. Instantiating 
a Mechatronic Valve Schedule for a Hydrocephalus Shunt, in Conf Proc IEEE 
Eng Med Biol Soc. (EMBC2009), Minnesota, USA, pp. 749-752, Sep 2009.
3. L. Momani, A. Alkharabsheh, N. Al-Zubi, and W. Al-Nuaimy. Reduction 
of Mechatronic Shunt Dependence for Hydrocephalus Patients, in 4th An­
nual Symposium of the Benelux Chapter of the IEEE Eng Med Biol Soc. 
(EMBS2009), University of Twente, the Netherlands, Nov 2009.
4. A. Alkharabsheh, L. Momani, N. Al-Zubi, and W. Al-Nuaimy. A Real- 
Time Self diagnosis Method for a Hydrocephalus Shunting System, in 4th 
Annual Symposium of the Benelux Chapter of the IEEE Eng Med Biol Soc. 
(EMBS2009), University of Twente, Netherlands, Nov 2009.
5. A. Alkharabsheh, L. Momani, N. Al-Zubi, and W. Al-Nuaimy. A Bidirec­
tional Wireless Management Protocol for Mechatronic Shunting System, in 
4th International Conference on Broadband Communication, Information 
Technology and Biomedical Applications, Wroclaw, Jul 2009.
6. A. Alkharabsheh, L. Momani, N. Al-Zubi and W. Al-Nuaimy. An Intelli­
gent Implantable Wireless Shunting System for Hydrocephalus Patients, in 
Proceedings of 13th International Conference on Biomedical Engineering, 
Suntec, Singapore, pp. 210-215, Dec 2008.
7. A. Alkharabsheh, L. Momani, N. Al-Zubi and W. Al-Nuaimy. Multi-Agent 
Approach for Self-Diagnosis of a Hydrocephalus Shunting System, in third
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International Conference on Developments in eSystems Engineering (DESE2010), 
london, UK, pp. 39-43, Dec 2010.
1.5 Thesis Structure
This thesis is organised in nine chapters. Chapter 2 is introductory where hydro­
cephalus is surveyed, providing a background of the causes and current treatment 
approaches with their drawbacks, which is necessary for the following chapters. 
Chapter 3 presents the proposed intelligent shunting system. In Chapter 4, the 
clinical data used in verification is presented and the ICP signal morphology is ex­
plained along with proposed analysis method using principal component analysis 
(PCA) followed by interpretation of the results. The applicability of this method 
in hydrocephalus classification is also discussed. Chapter 5 develops a practical 
ICP model with model parameters optimisation technique accompanied with the 
assessment and statistical analysis to show its accuracy in personalise patients. 
Also, Chapter 5 is concluded with an algorithm that can estimate posture angle 
form the ICP variation. The theme in Chapter 6 is the shunt settings optimise!', 
which presents an optimise!' approach for the settings of current differential pres­
sure shunt, tackling one of the current shunt problems. Chapter 6 also presents 
a similar optimise!' for a suggested new type of shunts which depends on time 
schedule as a regulating parameter for the valve. Chapter 7 carries the shunt into 
a more innovative step, by introducing intelligence in a shunt and using it in a 
more advanced step in hydrocephalus treatment to satisfy the patient in the short 
term and at the same time pursue a shunt arrested plan to wean the patient off 
the shunt. Finally in Chapter 8, main conclusions and recommendations for future
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work are given.
Chapter 2
Hydrocephalus and Shunts
Hydrocephalus is a condition in which the primary characteristic is excessive ac­
cumulation of CSF in the brain due to problems in the drainage process in the 
normal pathways. To demonstrate this condition, a literature review was carried 
out and presented in this chapter. It covers background in hydrocephalus intro­
ducing different related terms to the hydrocephalus as cerebrospinal fluid (CSF) 
characteristic and intracranial pressure (ICP) behaviour, hydrocephalus types and 
current and new treatment procedures. Current valves used are reviewed and their 
drawbacks are also discussed. Recent advances in valve technology are also fol­
lowed and their drawbacks are discussed
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2.1 Cerebrospinal Fluid (CSF)
Cerebrospinal fluid is a watery liquid produced in the parenchyma i.e the neuronal 
tissue of the brain, with approximately 60% from the choroid plexus. CSF acts 
as a cushion that protects the brain from shocks and supports the venous sinuses. 
It also plays an important role in the homeostasis and metabolism of the central 
nervous system [5, 23]. In healthy individuals, the CSF flows from the lateral 
ventricles into the third ventricles, down the audacity towards the sagittal sinus 
and spinal sac. It is assumed that this is principally reabsorbed in the top of the 
cranial vault, through granulations near the sagittal sinus, although recent studies 
suggest that several distinct CSF transport pathways may exist. There is usually 
about 150 ml of CSF in the intracranial space at any given time, of which 25 ml 
is in the ventricles, 75 ml is in the spinal subarachnoid space and 30 ml is in 
the cerebral subarachnoid space. The rate of absorption correlates with the CSF 
pressure.
Fourth ventricle
Figure 2.1: Ventricles in the brain.
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Table 2,1: Normal intracranial pressure (ICP) values [27]
Age Normal ICP in mmHg
Adults 10-15
Children 3-7
Infants 1.5-6
2.2 Intracranial Pressure (ICP)
Intracranial Pressure (ICP) is defined as the pressure within the skull and thus 
in the brain tissue and cerebrospinal fluid (CSF); this pressure is exerted on the 
brain’s intracranial blood circulation vessels. Normal ICP is affected by age and 
posture of the body and it is not a static pressure but varies with arterial pul­
sation, with breathing and during coughing and straining [24, 25]. Normal ICP 
in a supine healthy adult ranges between 7 and 15 mmHg, while in the vertical 
position it is negative with an approximate mean of -10 mmHg but not exceeding 
-15 mmHg [26]. Normal values in children are between 3 and 7 mmHg, while in 
infants 1.5-6 mmHg is considered normal, as listed in Table 1.
The skull can be modelled as a rigid closed box containing the brain, cerebrospinal 
fluid (CSF), arterial blood and venous blood, each of the intracranial constituents 
occupies a certain incompressible volume. If one of the intracranial constituents 
increases in size, then it should be compensated by either a decrease in size in one 
of the other constituents or a rise in the ICP [25]. Raised intracranial pressure 
(ICP) is a common neurosurgical problem, and it happens due to many causes, 
such as acute or chronic disturbance in cerebrospinal fluid (CSF) circulation and 
is a primary indication of hydrocephalus.
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2.3 Hydrocephalus
Hydrocephalus is disorder condition arise from an excessive accumulation of CSF in 
the ventricles of the brain. This build-up of fluid is a result of excessive production 
of CSF or insufficient absorption of CSF and a blockage of drainage pathways. This 
leads to ventricles expansion with a compression in the brain causing an elevation 
in intracranial pressure in adults or expansion of the skull. The body compensates 
for this increase in ICP by increasing the arterial blood pressure (ABP) to maintain 
the cerebral perfusion pressure (CPP), as in (2.1), to be able to provide the brian 
with sufficient oxygen and metabolic products.
CPP = ABP - ICP (2.1)
However, this compensation is limited due to limited increase in blood pressure, 
causing a decline in cerebral perfusion pressure, leading to the occlusion of circu­
lation and cell death [4, 5],
Hydrocephalus is accompanied by symptoms which may include headache, vom­
iting, nausea or coma, which usually depend on the cause of the blockage, the 
patient’s age, and how much brain tissue has been damaged by the swelling [28]. 
Hydrocephalus can be caused by impaired cerebrospinal fluid (CSF) flow, reab­
sorption, or excessive CSF production. Based on its underlying mechanisms, hy­
drocephalus can be classified into communicating and non-communicating (ob­
structive) , where both forms can be either congenital or acquired [29].
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2.4 Hydrocephalus Treatment and Shunts Func­
tionality
Hydrocephalus patients are characterised as an elevation in the ICP compared to 
healthy people as demonstrated in Figures 2.2 and 2.3. The dominant treatment 
for hydrocephalus is to divert the CSF from the ventricles in the brain to another 
part of the body by means of an implanted shunt. A catheter is inserted into the 
ventricles in the brain to collect CSF and convey it in a tube under the skin to 
another part of the body, as shown in Figure 2.4. In the tube, a pressure operated 
valve is configured to regulate the CSF flow through the shunt as illustrated in 
Figure 2.5, in an attempt to reduce the ICP and relieve the symptoms. Shunts, 
in this way, manage the symptoms rather than cure the causes of hydrocephalus.
Shunts are designed to respond to differences in pressure between the ventricle 
cavity and distal cavity where the CSF is drained to, hence they referred to as dif­
ferential pressure valved shunts. Current shunts are designed to respond at a set of 
pressure differentials, and are categorised into three groups, low opening pressure 
(~0 mmHg), medium (^4.5 mmHg) or high (~9 mmHg) [5], while the adjustable 
valves accommodate 18 valve settings from 2.2 to 14.7 mmHg in 0.736 mmHg in­
crements [30]. With various valve technologies and shunt approaches available in 
commercial use, however, they all have similar behaviour and functional charac­
teristic, in providing a bypass path for the drainage of excess fluid. The current 
criteria for selection of the valve opening pressures are not well-defined and not 
patient specific because the rate of CSF production and the pressure-flow relations 
are not precisely known in individual patients [8].
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Increased
ICP
0
Figure 2.2: Intracranial pressure (ICP) in Healthy human, a) recumbent po­
sition and b) upright body position, original figure from [31].
Increased
ICP
0
♦
ICP
a) b)
Figure 2.3: Intracranial pressure (ICP) in Hydrocephalus patient, a) recum­
bent position and b) upright body position, original figure from [31].
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Negative
ICP
ICP = 0
0
a) b)
Figure 2.4: Intracranial pressure (ICP) in Hydrocephalus patient with a tube, 
a) recumbent position and b) upright body position, original figure from [31].
Figure 2.5: Intracranial pressure (ICP) in Hydrocephalus patient with a shunt 
(i.c. tube and valve), a) recumbent position and b) upright body position,
original figure from [31].
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2.5 Shunts Components and Types
A shunt consists of at least 3 elements: proximal catheter, valve and distal catheter, 
as indicated in Figure 2.6. The proximal catheter is the upper end of the shunt 
that is placed in the brain’s fluid chambers.
Catheter into 
ventricle —J-
Shunt valve
Tubing to the 
abdomen — 
(or heart) f
Brain
Cerebrospinal
fluid
Figure 2.6: An implanted hydrocephalus shunt, original diagram from [32].
Distal catheter is the ending point of the shunt that drains CSF to one of several 
body cavities. Based on distal cavity, different shunt types are categorised: right 
atrium of the heart via the jugular vein (ventriculo-Atrial VA shunt), abdominal 
cavity (Lumbo-Peritoneal LP shunt), peritoneal cavity (ventriculo-Peritoneal VP 
shunt), chest cavity and recently major blood sinuses, as shown in Figure 2.7 [5] 
(e.g., the sagittal sinus) draining blood from the brain. Nowadays, the peritoneal 
cavity is the favoured common distal site for shunt placement (ventriculoperitoneal 
shunt). It is a large cavity, more than capable of handling any amount of CSF 
delivered by the shunt in all but the most unusual cases.
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Valve is used to regulate the flow of the CSF between the proximal and distal 
catheters.
Zero-level of the sinus
Hydrostatic pressure 
in
VA-s hunts
Zero-level of the heart pressure
H
Hydrostatic pressure 
in
VP- and LP-shunts
Zero-level of the 
abdominal pressure
Figure 2.7: Shunt types, according to distal catheter end, original figure
from [31].
2.6 Valves Dynamics
Different types of valves are available with different flow rate response to differ­
ential pressure to regulate the shunt. Most of the commercially available shunt 
valves are quasi-linear (linearly behaving but with a little nonlinearity at very low 
flow rates), and these are considered in this work. As shown in Figure 2.8, above 
a threshold opening pressure Pth the valve opens and the flow of CSF q is subject 
to a resistance rv, as indicated in (2.2).
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Q =
0 , ICP< Pth
ICP-Pq,
rv ICP > Pth
(2.2)
Closed
valve
Opened
valve
(ICP-Pth)
Figure 2.8: Differential pressure valve characteristic where ICP is the in­
tracranial pressure, q is the flow through the catheter, rv is valve resistance and 
Pth is the opening threshold pressure of the valve.
However, some materials used in valve manufacturing, such as silicone, are easy 
to deform and have a non-perfect elasticity and may have adhesive properties. 
The mechanical behaviour of such material is the reason for differences between 
opening and closing pressures. Whereas the opening pressure refers to the pressure 
level at which the valve opens, and the closing pressure is defined as the pressure 
level when the valve closes during decrease of pressure. The shape of the silicone 
material tends to adapt slowly to altered flow conditions. As a result there is a
Chapter 2. Hydrocephalus and Shunts 24
bad reproducibility (hysteresis) of flow-pressure relationship when comparing the 
curves resulting from a low to a high flow and reverse [33].
These valves and their settings (i.e. opening pressure and flow resistance) are 
selected by the surgeon so that the rate of flow through the shunt at the desired 
maximum pressure is in balance with the given rate of cerebrospinal fluid accu­
mulation. Difficulties with the biomechanics of the changes in the condition of the 
patient with time lead to a high rate of complications in hydrocephalus shunting 
and selecting proper valve settings.
2.7 Valve Categories
Different types of valves are available with different flow rate response to differ­
ential pressure and are categorised into three groups, low opening pressure (~0 
mmHg), medium (~4.4 mmHg) or high (~8.8 mmHg) [5]. However, while these 
figures may be roughly correct when the patient is recumbent, there is a complete 
change in the upright position. The result is the pressures within the head drop 
into the negative range as CSF is sucked out of the head by siphoning and over­
drainage of the ventricles can occur. This is true regardless of which type of simple 
pressure differential valve is utilised. There is no physiological correlation between 
the type of valve, the intracranial pressure, and the outcome of surgery. Nor is 
there at this time any convincing evidence that one pressure setting is universally
better than another.
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2.8 Valve Classification
There are several different types of hydrocephalus valves depending on the me­
chanical principle and components.
• Differential pressure valves: Demonstrated in Figure 2.9.
1. Silicon-Slit-Valve: These valves consist of a slit in a silicone layer. The 
principle is based on memory properties of silicone: after deformation the 
material will resume its original shape, which may take a variable time in 
the range of seconds to days. There are two types of slit valves: proximal 
and distal slit valves. The proximal valves consist of either a side slit at 
the lower catheter-end, or they may have one or multiple slits at the upper 
end [33, 34].
2. Membrane-Valve: The principle of this type is based on a mobile and flexible 
silicone membrane which moves in response to pressure differences, leading to 
a circular flow pattern. The hydrodynamics of this valve depend on elasticity, 
tension and thickness of the membrane as well as on shape and size of the 
orifice in the valve. There is a risk that the membrane may collapse at 
excessive pressure differences. Another problem is the non-linear increase in 
resistance of the membrane with enlargement of its surface which may lead 
to overdrainage. Because the valve is made of silicone, basic problems as 
hysteresis and drift may arise, e.g. PS medical, Pudenz and Accu-flo [33, 34].
3. Ball in Cone-Valve: The mechanical principle of this type of valve is a metal­
lic spring exerting force on a ball which is located at a conical orifice that can 
be occluded by the ball. The ball used to be made of metal, but currently it
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is made of industrial corrundum (saphire or ruby). The hydrodynamic char­
acteristics of this valve depend on tension and deformability of the spring on 
one hand and of the cone shape and diameter on the other hand. Because 
silicone rubber is not used in this valve, there are no problems like hysteresis 
and drift. This valve incorporates an on/off principle, leading to a high flow 
immediately after the opening of the valve which might bring an increased 
risk of overdrainage, e.g. Hakim valve [33, 34].
silicone slit 
valve
membrane
valve
■ Ball in cone Hi valve
Figure 2.9: Differential pressure valves [13].
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• Adjustable valve: Demonstrated in Figure 2.10.
These valves can be programmed to change the opening pressure of the 
valve non-invasively between a range of pressures. Adjustable hydrocephalus 
shunts are very popular in management of hydrocephalus. They are supposed 
to help in minimizing the number of invasive revisions. Drawback of almost 
all constructions is that they may be accidentally readjusted in relatively 
weak magnetic field (around 30-40 mT) [34].
Valve seat
Figure 2.10: The internal structure of the adjustable valve [13].
• Flow regulation valves: Demonstrated in Figure 2.11.
Flow regulation and anti-siphon valve: A tight conical cylinder is inserted 
into a ring which is attached to a pressure-sensitive silicone membrane. The 
inner diameter of the ring is slightly larger than the outer diameter of the 
conical cylinder. The distance between cylinder and ring varies with the 
pressure, leaving more or less space for the passage of CSF. The system is
Chapter 2. Hydrocephalus and Shunts 28
vulnerable and sensitive to increased proximal pressure. The membrane is 
easily damaged, and the ring or cylinder may dislocate [34].
membrane
Figure 2.11: Internal structure of the the flow regulation valve [13].
2.9 Problems with Current Shunts
Passive shunts are being the standard treatment for hydrocephalus more than 
40 years. However, they still suffer from many drawbacks. These drawbacks lie 
mainly in two categories; under-drainage and over-drainage, in addition to that 
many other shortcomings, such as infection and blockage, and for certain types 
of shunts a house-hold magnetic field affect. In under-drainage and over-drainage 
the CSF is either drained in less than required or more than enough. The causes 
for over/under-drainage are often improper valve opening and closing in respect 
of either opening pressure and flow rate settings.
Underdrainage is usually because of either blockage in the valve or the tubes 
of the shunt or improper valve settings. This blockage may be caused by growing 
tissue, shunt breaking or disconnecting parts. While improper valve settings hap­
pened due to incorrect selection of valve opening pressure and flow rate settings. 
The signs and symptoms of underdrainage are characterised as high pressure of 
CSF fluid. The ICP is not always ready to measure, so the other symptoms are
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used in diagnosing. These symptoms are seen as headache, tiredness, change in 
behaviour or deterioration in intelligent capability. Shunt blockage is sometimes 
difficult to notice in the beginning. It may need other diagnosis procedures such 
as CT scans or X-rays [4].
Draining the CSF more than required is another problem of the current shunt and 
is called overdrainage (siphoning effect). One of the causes of such effect is 
the difference in the pressure between the proximal and the distal catheter. This 
may happen due to body angle which represent patient’s posture i.e. standing or 
lying. Over-drainage may cause the ventricles of the brain to collapse, causing 
internal bleeding.
To overcome the siphoning effect, many shunts are equipped with anti-siphon 
devices to minimise the transient changes between body postures. The anti-siphon 
device closes when the pressure becomes negative relative to atmospheric pressure 
and opens when the intraventricular pressure increased [35]. Programmable valves 
are used to adjust the opening pressure of the valve invasively. However, these 
valves still experience over-drainage [36].
Diagnosing overdrainage or underdrainage is a difficult task. This can be done 
by monitoring ICP using an external pressure monitor in the scalp connected to 
a recorder, but this method has drawbacks summarised in possibility of infection 
and bleeding. Adding to that this method lacks accuracy in measurement. So the 
current intention nowadays is the usage of an implanted ICP sensor with capability 
of wireless communication [37].
The inability of current shunts to adapt themselves to the dynamic behaviour of 
the CSF is considered the cause of the over/under-drainage problems. Inaccuracies
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and long term drift in valve opening pressure and flow regulation are also consid­
ered among the drawbacks of such shunts. This is because they are controlled 
through the differential pressure across the valve. Adding to that the inefficient 
criterion for selecting the valve settings. Another problem with the programmable 
shunt valves is that their settings are subject to changes by the external household 
magnets [38, 39]. With these drawbacks of the current shunts, i.e. overflow, un­
derflow, inaccuracy, and long-term-drift [5, 6], these shunts can not be configured 
to satisfy patients’ needs. This is clear from multiple shunt revisions and shunt 
failure rate which is in the range of 30% to 40% of all shunts placed in pediatric 
patients [9, 10, 11, 12].
Some studies show that for most patients their natural drainage system is partially 
malfunctioning (blocked), and are referred to as partially shunt dependent. Pa­
tients are varied in their shunt dependance from fully shunt dependent to partially 
shunt dependent [6], This clarifies the fact that the current shunts behaviour do 
not help in reducing shunt dependency, but they let the normal drainage path­
ways rely on the artificial path for drainage and make the patient to be fully shunt 
dependent. Studies show that it could have the shunt dependence to be reduced 
to less than 1% in some of patients’ cases [6]. This could lead in the end to wean 
the patient off the shunt [6, 16].
So the new development expected in the forthcoming shunt should be directed 
towards hydrocephalus treatment, not just managing the ICP level. This is clear 
from the intention in the shunt designers who have modified the shunt functionality 
to be able to remove shunt at the end [6]. The current shunts also lack the 
personlisation and do not take individual patient’s needs into consideration, as 
they are used for limited settings categories and applied for all hydrocephalus
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patients without discrimination in their needs. The difference in the behaviour 
of the intracranial hydrodynamics among patients is the main reason of shunt 
unsuitability for patients, as the cerebrospinal fluid dynamic behaviour is affected 
by many reasons such as age, gender and lifestyle.
2.10 Recent Advances
A recent development in shunt technology is the invention of the mechatronic 
valve [13]. In this valve, a software is driving an electrical system which controls 
the opening and closing periods of this valve. This development opens the door for 
many shunt systems to be developed. The mechanism in which this valve operates, 
motivates the integration of intelligence in the way of controlling the valve [22]. 
The controlling system could take the simple form of switching with fixed time 
and periods to a complex one which could be dynamic in its behaviour.
Another advance is in the ICP monitoring methods. This can be due to the need 
for repeated measurements of the ICP, and sometimes for long periods. In spite of 
that ICP measuring nowadays can be measured invasively, it motivates the need 
for being online for real time readings. This is implemented by a telemetric system 
with implanted ICP sensor [37]. This development in measuring the ICP gives the 
physician the capability of measuring the ICP in real time and adjusting the valve 
settings accordingly.
Latest development in this hydrocephalus field is the development of a flowme­
ter, developed by Transonic Systems Incorporation. It integrates a transcuta- 
neously powered flow probe combined with standard shunt tubing. Its function is
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to measure the dynamic flow volume by transmitting ultrasonic pulses trough the 
tube [40]. This gives the possibility of enhancing the functionality of the current 
shunt to be adapted to the patients’ needs.
2.11 Conclusions
Introducing hydrocephalus and reviewing its causes and current treatment empha­
sizes the needs for a new generation of shunts that could enhance the functionality 
of the current shunts in managing hydrocephalus mid motivate the work toward 
treating it by reducing shunt dependence. The invention of the mechatronic and 
the implantable ICP sensor lay the platform for such shunting system develop­
ment. This anticipated shunting system could in the first stage overcome the 
current problems of current shunts, then improve them to become autonomous 
and proactive in responding to patients’ needs.
Raising the problems in the current shunt behaviour gives the priority to have 
a new method for proposing shunt settings that suit each patient. This could 
rehabilitate the current shunts. Further investigating in the long term problems 
in the current shunt shows that current shunts deteriorate the functionality of the 
natural drainage pathways. This sheds the light on the necessity of having a new 
shunting technique that could treat hydrocephalus.
Chapter 3
Proposed Treatment Approach1
The recent invention of a mecliatronic valve which can be controlled by software 
and the recent development of the implanted pressure sensor, this with the abil­
ity of using a sensor to measure the body posture angle, and the deficiencies in 
the current shunting systems, all these motivate the integration of these develop­
ments into an intelligent shunting system. That could provide personalised and 
autonomous treatment and management of hydrocephalus patients.
This work proposes a new shunting technique that incorporates an implanted pres­
sure sensor, electronically controlled valve and an intelligent agent software. By 
this combination, a suitable environment for agent application is presented. The 
implemented agent exhibits its known characteristics like autonomy to operate 
without the direct intervention of physician, reactivity to respond to the percei-
lPart of this chapter have been published in “Distributed Multi-agent Approach for Hydro­
cephalus treatment and management Using Electronic Shunting”, in HEALTHINF, Portugal, pp. 
503-507, Jan 2009 [41]. and “Treatment and Management Methodology of Hydrocephalus: Ap­
plication of Electronic Shunt Multiagent System (eShunt)”, in Second International Conference 
on Developments in eSystems Engineering (DESE), Abu Dhabi, pp. 147-150 , Dec 2009. [42]
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ved changes in ICP waveform environment, and pro-activeness to take the ini­
tiative when appropriate [43, 44].
3.1 Review of Developments in Shunts and Im- 
partable ICP Sensors
Developing an intelligent shunting system that provides a personal treatment for 
each patient is considered innovative development, as only humble attempts were 
tried before. In the literature review, such attempts are summarised in implement­
ing a programmable hydrocephalus valve in which the opening pressure could be 
adjusted invasively by the physician according to the patient’s needs. While the 
term “intelligent shunt” was limited to the development of an implantable pres­
sure sensor with a transceiver that sends ICP readings wirelessly to an external 
unit. These data could be analysed by a physician who can modify invasively the 
programmable valve settings, such as valve opening pressure.
One of the trials in this area is the development carried out by Zoghi and Raster- 
gar [43]. They implemented an implantable intracranial pressure (ICP) sensor 
using a transmission optical approach. The proposed sensor wias composed of 
a pressure-sensing membrane, an optical transmitter and receiver, and a signal 
transport mechanism. Two transport mechanisms were investigated, either using 
a fiber optic approach or telemetric approach. Selection one of each is depending 
on the application [43, 44]. The idea of implantation of such a sensor could provide 
the environment for developing an intelligent shunt. Also it could provide the tool 
for online monitoring of patient’s status.
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By their design of the implantable ICP sensor, Zoghi and Rastergar think about 
using this facility to create a system that could control the valve operation based on 
direct measuring of the ICP, rather than using the passive operation that depends 
on differential pressure across the valve. The design could enable the surgeon 
to design valve characteristic which satisfy patient’s needs. Adding to that, this 
design could enable the monitoring of the ICP externally [43].
A nonlinear closed-loop control system was designed and tested by Cote et al. [45]. 
The closed-loop system is used to regulate the intracranial pressure (ICP) through 
adjusting the volume of the CSF. In this design, Cote et al try to overcome some 
of the problems of the passive differential pressure shunts by giving the control 
system the ability to adjust the pressure-flow characteristic of the valve.
Johannessen et al. [46] have implemented a telemetry system, ustilising more than 
one sensor to measure ICP. These sensors were integrated with a wireless interface 
that could communicate with an external unit. This system was optimised for low- 
power and included mixed signal sensor circuits, a programmable digital system, 
a feedback clock control loop and RF circuits. An external unit was implemented 
to receive the ICP readings from the implanted system. The external system was 
optimised to reduce power consumption. The whole system was tested and verified 
through an experiment on animal cases. This trial was carried out to verify the 
efficiency of the communication link with the saving power proposed.
Chatzandroulis et al. [47] have implemented an implanted miniature telemetric 
pressure monitoring system. This system uses passive telemetry to transfer power 
to the transponder and pressure data to the remote base unit. The sensing ele­
ment uses a new technology utilises a capacitive pressure sensor based on SiGeB 
diaphragm. The advantage of using the capacitive pressure sensor with telemetry
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system is that it consumes less power. The pressure sensor is connected to an 
integrated interface circuit, which includes a capacitance to frequency converter 
and an internal voltage regulator to suppress supply voltage fluctuations on the 
transponder side. In addition, the sensor and accompanying interface circuit take 
up very little space so as to be suitable for implantation.
Man waring el al. [48] have also implemented a wireless implantable device to mon­
itor the intracranial pressure. This device is externally powered and implemented 
using a low power microprocessor and small dimension pressure transducer. The 
developed intracranial pressure monitor system eliminates the need for the battery 
power supply, and thus avoids the hazards associated with potential leaking of the 
batteries. Another advantage of the system is its wireless mode of operation. By 
keeping the interrogator in the close proximity of the patient skull, for example 
in the patients pillow, the system can be used for continuous monitoring of the 
intracranial pressure, even while the patient sleeps. A natural extension of the sys­
tem is to connect the interrogator to a phone line or data network, the ultimate 
goal being to enable remote monitoring, logging, and analysis of the intracranial 
pressure.
An implantable stand-by device for measuring intracranial pressure and tempera­
ture under normal conditions has been implemented Flick el al. [49]. This device 
consists of a sensor element combined with a transcutaneous telemetric interface. 
One of the main points is automatic event recognition, used as a switch between 
the sampling rates in order to capture special signal component in an emergency 
situation. Therefore, a signal processing and waveform analysis is exigent, first to 
control the measured signal online on the portable unit, and second to process the 
data offline on the stationary unit.
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3.2 Approach of the Proposed Shunting System
In this research, the hydrocephalus treatment and management are tackled from 
four different aspects* The main contribution is an intelligent shunt that could 
help not just in managing hydrocephalus in the short term but curing it in the 
long term if weaning program shows good progress. A subsystem of the intelligent 
shunt is configured as an off-line autonomous optimiser that can help in proposing 
optimum valve settings, either for the traditional differential pressure shunts for 
their opening pressure and flow rate settings or the recently proposed time-based 
shunts for their time schedules. A new analysis method is proposed that shows 
promising results which could be used in diagnosing hydrocephalus and classifying 
patients. These contributions are demonstrated in Figure 3.1.
3.2.1 Intelligent Shunt
In this research, a new approach to shunting is proposed to help improve the 
personalised management, treatment and outcome following diagnosis with hy­
drocephalus. This approach develops and utilises a software agent integrated with 
the recent developments in shunt equipment (i.e. software controlled valve, im­
planted pressure sensor and posture angle sensor) and involving the CSF dynamics 
model. This shunt agent can “learn” from the direct patient’s ICP readings and 
act according to the patient’s need. These aspects of this approach are further
elaborated below.
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• Personalisation:
The proposed shunt will be initially implanted with a minimum configuration 
such that the settings are configured to current shunts (i.e. opening pressure 
and flow rate resistance), then the shunt personalises itself to that spacific 
patient by perceiving the ICP data and learning to optimise a CSF dynamic 
model that reflects the patient’s CSF environment. The behaviour of this 
CSF model after its parameters are configured and optimised imitates the 
behaviour of the patient’s CSF environment, and the generated ICP traces 
from the model are resembles the perceived readings. This innovative step 
in providing an analogous environment to the actual patient’s CSF environ­
ment enables the use of the intelligent agent and machine learning methods 
in such medical application. And by this method, the optimised CSF model 
can be queried by the agent to either diagnose the patient’s current state or 
predict the response to a specific therapeutic intervention. Adding to that, 
this technique in modeling can use some parameters of the CSF dynamics 
as inputs such as ICP traces and posture angle to estimate the other param­
eters which would be difficult to measure. These parameters, such as CSF 
production and absorbtion rate would be of great help in recognising the 
nature of the CSF dynamics and the hydrocephalus for that specific patient, 
which could provide a personalised management and treatment of CSF.
• Management:
Since the implantation and installation of the intelligent shunt in the patient, 
it manages the CSF flow through the valve to keep the ICP within the normal 
levels. The shunt, in this case, perceives the ICP and senses the posture angle 
and based on a preset values of the normal level ranges in different posture 
angles (i.e. recumbent and erect positions) controls the opening/closing
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times and periods of the valve. This closed loop behaviour of the shunt 
has the advantage of avoiding many drawbacks of current shunts, such as 
the main drawback which is over and under-drainage. And by invoking the 
ICP model and deriving benefit from its parameters such as CSF production 
and absorption rate, this could also provide accurate tuning to the regulation 
of the valve rather than just the level of the ICP. Where this valve controlling 
factor could redound to the treatment of the normal pressure hydrocephalus 
as the ICP level in this type of hydrocephalus is within the normal levels. 
With this beneficial capability of this shunt, it could be utilised in shunt 
malfunctioning and blockage detection.
• Treatment:
As it is believed that the the normal absorption paths are still functioning 
to a certain extent in most cases of hydrocephalus, the current shunting 
technique causes the normal drainage system to rely on the artificial drainage 
systems and does not let the skull and the absorption system accommodate 
properly to the CSF being produced. And as it is unnecessary to remove 
certain part of the produced CSF volume a day [15], hence there is part of 
the CSF which is normally drained through the normal absorption system. 
With the infrastructure of the proposed shunt, its function can be directed 
toward enhancing the effectiveness of the normal absorption system in the 
long term. The proposed intelligent shunt, equipped with a machine learning 
algorithm, can gradually control the opening/closing times and periods of 
the valve with the purpose of stimulating the normal absorption pathways, 
preparing for shunt weaning in cases showing successful compliance, that is 
either to adapt the patient gradually to higher ICP levels or reactivating the 
natural CSF pathways and improving their functionality.
Chapter 3. Proposed Treatment Approach 40
• Evaluation of Management and Treatment:
A figure of merit (FoM) of the current state of the patient is proposed to 
determine whether things have gone better or worse than expected. The 
calculation of the figure of merit is carried out in the learning algorithm in 
the shunt and based on the evaluation of certain parameters of the optimised 
model such as evaluating the ratio of CSF absorbed to the CSF produced 
every certain time intervals.
3.2.2 Shunt Settings Optimiser
As intracranial pressure is critical for hydrocephalus patients, and as reported 
from the drawbacks of the current shunts, wrong or improper shunt valve pres­
sure settings will either increase ICP causing brain damage or overdrain the CSF 
breaking the ICP balance. And if differences among patient states are taken into 
consideration it becomes important that valve settings are properly chosen for 
each patient so that normal ICP levels are preserved. At present, these pressure 
settings are still determined by the surgeon and physician experience based on a 
clue from the ICP traces and repeat hospitalisation is often required.
A subsystem of the intelligent shunt is configured as an off-line autonomous opti­
miser that can help in proposing optimum valve settings, either for the traditional 
differential pressure shunts for their opening pressure and flow rate settings or 
the recently proposed time-based shunts for their time schedules. This method 
presents a precise and efficient way for the ICP model can be utilised in evaluating 
the patient’s ICP traces and hence proposing a personalised optimal valve opening
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pressure setting for each individual patient. This shunt optimisation method is 
performed into two steps:
• Model Characterisation:
To optimise the shunt settings for a specific patient, an ICP model is opti­
mised first by adjusting its parameters to reflect the patient’s parameters. 
The primary input to the optimiser is just the real ICP traces recorded prior 
the insertion or revision of the shunt. Based on these traces, the posture an­
gle and other patient information like his/her height, the optimiser optimises 
the model parameters to characterise the patient.
• Shunt Optimisation:
In the second step, the optimised model is used to optimise the shunt param­
eters. In this way personalised settings are tailored for each specific patient. 
These settings are configured according to the shunt type and patient status. 
For the differential pressure shunt, the opening pressure and flow rate of the 
valve are optimised to keep the ICP within the normal levels, while in the 
time-based shunt, the time schedule for the valve is similarly determined.
3.2.3 New Analysis Method
To optimise the diagnosis method in hydrocephalus and also following treatment 
outcome, a new method is presented in this work. This method quantitatively 
analyses the patients’ ICP traces and other information using a multivariate ap­
proach based on principal component analysis. This method goes into four stages:
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• Feature extraction:
The ICP waveform proves to carry a lot of useful information and the data 
acquired from waveform recording are valuable to extract relevant informa­
tion about the state of the patient. For this, 10 features are extracted from 
the ICP sinal to represent valuable information about the ICP signal rather 
than just the mean ICP feature. These features are extracted using a moving 
time sequence window of 6 seconds then averaged over one hour periods
• Multivariate representation:
A multivariate analysis method using Principal Component Analysis (PCA) 
is used to represent and interpret the large and complex data set.
• Patients1 classification:
In this stage, the generated principle components are used to characterise 
subgroups within patient population.
• Investigation of other non-ICP variables:
Then to investigate the effect of certain factors on these groups, an introduc­
tion of supplementary (non-ICP) variables has offered insight into additional 
groupings and relationships which may prove to be a fruitful avenue for ex­
ploration.
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ICP waveform analysis
Intelligent shunt
Figure 3.1: Overview of the main contributions in this work
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3.3 Advantages of Proposed Solution
The proposed shunting system is based on a machine learning software controlling 
valve. The potential benefits of such implementation are obvious in overcoming 
many of the current shunts drawbacks and improving the quality of shunting:
• Reducing over/under-drainage and elimination the changes in the drainage 
system due to posture valuation is achieved by sensing the ICP level and 
posture angle and according to that controlling the valve.
• Adaptation of the valve function to the individual patient’s need is achievable 
by estimating his/her CSF parameters.
• Autonomous management and treatment with intervention is possible through 
self-learning algorithm. This enables satisfactory control of the fluid drainage 
in the long term.
• Suitable for evaluating shunt dependency and pursuing shunt removal in the 
long run.
The proposed shunt off-line optimise!' can be of great help in presenting a precise 
and efficient method for proposing a personalised optimal valve settings for each 
individual patient.
The new analysis method provides a useful tool in optimising symptom diagnosis, 
patient characterisation and treatment simulation and personalisation. It provides 
a method in characterising patients into subgroups and interpretation of useful 
trends from the ICP signal and other patient data.
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3.4 Limitations of Proposed Solution
As the proposed system in this work offers a number of advantages over the cur­
rent systems, it still has limitations that could delay its implementation. From 
these limitation is the implementation of this system in the real environment and 
moving this to the patient situation. This step, at the first, needs the coopera­
tion of physicians and surgeons as using new technology in medical application 
considered as a critical decision to take. Another limitation which faces any new 
development is that it needs more testing and verification. Even that simulation 
shows a satisfactory results, it still need to be tested in a real environment.
One of the limitation in using and evaluating more the proposed analysis method 
of the I CP and other patients information is the availability of data. It is difficult 
to get suitable representing data of hydrocephalus patient. As this study needs a 
careful ICP recording with annotated details about the patient’s status, and that 
is what we were unable to get even with repeated attempts.
The speed of data processing and algorithm evaluation, and the speed and accuracy 
of the ICP sensors add another challenges of the implementation of the proposed 
shunting system. In terms of power source and power consumption is another 
challenge in this system, however that these limitation are being fixed through 
different approaches.
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3.5 Conclusions
Taking the benefits of the development of the new mechatronic valve and the new 
implantable pressure sensors open the door for more promising shunting technique. 
The proposed shunting system in this work utilises these developments and inte­
grates them with a machine learning algorithm. This shunting system is enforced 
with a model that mimics the patient’s CSF hydrodynamics. Such shunting sys­
tem gives the ability to be autonomous as it has the ability to sense the patients’ 
status and the ability to take a proper decision, which could reduce the risks and 
overcome many drawbacks of the current system. Implementing this system would 
improve the option of managing the hydrocephalus, as current shunts targeting, 
and treating hydrocephalus as advance step.
This optimistic view of this shunt and the persistent of the drawbacks in the 
current shunts, motivates this work. Thus, preparing work was carried out. These 
implied the development of an optimiser of the shunt settings which can be used 
as an offline system to overcome some of the current shunts, and then becomes 
a prime module of the proposed intelligent shunt. As an initial phase, a method 
is developed to analyse the patient information including the ICP signal, this 
method gives a tool for diagnosis and prognosis of the patient.
These developments would be a great enhancement in the behaviour of the current 
shunts and the accuracy and reliability of the current hydrocephalus patients’ diag­
nosing and following-up method. These development in shunting technique would 
provide an improving in the quality of managing and treating hydrocephalus.
Chapter 4
ICP Signal Morphology and 
Analysis2
The diagnosis and treatment of hydrocephalus and other neurological disorders 
often involve the acquisition and analysis of a large amount of intracranial pressure 
(ICP) signal. Although the analysis and subsequent interpretation of this data is 
an essential part of the clinical management of the disorders, it is typically done 
manually by a trained clinician, and the difficulty in interpreting some of the 
features of this complex time series can sometimes lead to issues of subjectivity 
and reliability. Adding to that, the current monitoring and therapy are mainly 
based on the mean ICP, since it is believed that the mean ICP contains most of 
the information provided by the ICP. Several researchers, however, have performed 
preliminary studies on the ICP signal and have suggested that the ICP beat may 
contain indirect information about the patient’s status [50, 51].
In this chapter, a number of extracted parameters other than mean ICP are sug-
2This work has been published in “Multivariate Analysis of Intracranial Pressure (ICP) 
Signal Using Principal Component Analysis”, in Proceedings of the IEEE Eng Med Biol Soc. 
(EMBC), Minnesota, USA, pp. 4670-4673, Sep 2009.
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gested and a method for the quantitative analysis of these parameters using a 
multivariate approach based on principal component analysis is presented. The 
aim of this method is to optimise symptom diagnosis, patient characterisation and 
treatment simulation and personalisation.
4.1 Introduction
Monitoring intracranial pressure (ICP) plays an important role in diagnosis and 
management of hydrocephalus and other head injury patients [52], this monitoring 
acquires vast amounts of ICP data. Although the current diagnosis procedure de­
pends mainly on the surgeons5 observation of the clinical symptoms, neuroimages 
and mean value of ICP recording, other aspects of the ICP waveform carries useful 
information about the status of the patient [18]. Data acquired from ICP record­
ing are valuable to extract relevant information about the state of the patient. 
However, these data are large, and time dependant, and physicians, biomedical 
engineers, or surgeons have only limited background knowledge on their interpre­
tation.
The following multivariate analysis method based on extracted features from ICP 
waveform allows the representation of time varying data using a Principal Compo­
nent Analysis (PCA) that can assist in the interpretation of ICP data. Actually, 
although PCA is among the most popular methods in analysis of multivariate 
signals, it has not yet been used in the analysis or interpretation of ICP data, to 
the author’s knowledge. The proposed method in this work uses PCA to identify
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the correlation between a number of signal features, and identifies the most re­
vealing features, additionally categorising patients into clusters according to these 
features. Figure 4.1 shows the block diagram of the proposed method.
Additional
Supplementary
Variables
ICP Signal 
Features 
Extracted
Principal 
Component 
Analysis (PCA)
Clinical Data
Figure 4.1: ICP signal feature extraction and processing diagram.
4.2 Clinical Data
Digital ICP recordings were taken using an intraparenchymal in the skull and these 
traces were recorded in cooperation with Walton Neurological Centre, UK [53]. 
Approximately 1482 hours of ICP recordings from 40 patients were analysed: 15 
patients (37%) were suffering from hydrocephalus with 547 hours of ICP record­
ings, and others had head injuries, but all were exhibiting symptoms. Ages of all 
patients ranged from 1 to 20 years, and male to female ratio was 1:1 (20 males 
and 20 females). Data was recorded at different sampling rates, 40Hz, 100Hz and 
400Hz, and recording length varied from 5 to 75 hours. Since the signal was cap­
tured at high sampling rate, the high frequency components of the signal were 
preserved, which keeps the important features of the ICP signal.
4.3 ICP Waveform Morphology
The ICP waveform has a semi-periodic beat that corresponds to each heart beat 
and pulse in the arterial blood pressure. The morphology of the ICP pulses are
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similar to that of the arterial blood pressure. The normal ICP pulse consists of 
three components as shown in Figure 4.2 [50], 'percussion (Pi) component, tidal 
(Pz) component, and dichrotic (P3) component. The lower value between the 
P2 and P3 components is defined as the dichrotic notch, and corresponds to the 
dichrotic notch in arterial blood pressure. The Pi is a sharp peak, with fairly 
constant amplitude modulated by respiration. The morphology of the ICP pulse 
is affected by its mean value, at low ICP mean levels, the Pi component is the 
highest among the components. P2 component is more valuable and is not always 
present in low-pressure ICP signals, where in high-pressure is always presented 
and has the highest amplitude [54].
Percussion peak
Percussion peak
Dichrotic peak
Dichrotic peak
Dichrotic
notch
Absent
Dichrotic notch
56.2 56.3 56.4 482.2 482.4 482.6 482.8
Time, s Time, s
ICP signal with low-pressure morphology ICP signal with high-pressure morphology
Figure 4.2: An example of ICP pulses of low-pressure and high-pressure, with
the components labelled [50].
A clear relation between the peaks of the ICP and the arterial pulse wave exists, 
and a subtle changes in the ICP due to ventilation are also presented.
Despite the similarity between ICP pressure signal and electrocardiogram (ECG) 
signal in morphology, they still have a different features in time-domain and spec­
tral density. The ICP pressure signals are more sinusoidal and less impulsive
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shaped than ECG signals, and most of the spectral density of the ICP pressure 
signals is in a lower frequency range (0.7-3.5 Hz) that includes the fundamental 
frequency compared with the spectral density of the ECG signal which lies in the 
range (10-25 Hz) [54].
The ICP waveform includes three distinct almost periodic components: heart rate 
pulse, respiratory waves, and slow vasogenic waves; these components overlap on 
a randomly changing mean ICP. Heart rate rages from 50-180 bpm, respiratory 
waves ranges from 8-20 cycles/min, and slow waves from 0.3-3 cycles/min, these 
can be identified using spectral analysis, as shown in Figure 4.3, the R1 - R5 
denote the respiratory component, the pulse waves with two harmonics PI and P2 
the fundamental one denotes the heart rate, and S component denotes the slow 
waves (all components within the range 0.05 - 0.0055 Hz are considered as slow 
waves [52]).
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Figure 4.3: An example of ICP waveform and its spectral representation 
showing the respiratory components (R1-R5) with narrow peaks due to hyper­
ventilation, pulse wave (P) and slow waves (S) [52].
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4.4 ICP Waveform Parameters
Even that the current diagnosis and management of the hydrocephalus is based 
on the mean ICP, the dynamics of the ICP signal is believed to carry useful 
information about the patient status. The following sections show some of the 
used parameters extracted from the ICP signal and their interpretation.
4.4.1 Pulse Amplitude of the ICP
Time-domain analysis is an another method for evaluation of the pulse waveform. 
It is used to calculate the peak-to-peak amplitude of ICP pulsation during one 
heartbeat. Both the frequency (Figure 4.3) and time (Figure 4.2) domain meth­
ods seem to be equivalent, as there is an excellent linear relationship between 
the amplitude of the fundamental component and peak-to-peak time-domain am­
plitude (R = 0.97). The amplitude of the fundamental component seems to be 
less influenced by the presence of noise and contamination from other components 
(such as respiratory and slow waves), but it may be affected by an irregular heart 
rate [52].
4.4.2 RAP Index
The RAP index is a correlation coefficient [R] between the amplitude of the fun­
damental component [A] and mean pressure [P]. The RAP can be derived by cal­
culating the linear correlation between consecutive, time-averaged (a 6-10 seconds 
averaging period is usually used) data points of the amplitude of the fundamental 
component and ICP (usually 40 of such samples are taken). This index indicates
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FIGURE 4.4: A spectral density of ICP waveform showing the respiratory and
cardiac activity arc shown [51].
the degree of correlation between the amplitude of the fundamental component 
and the mean ICP over short periods of time (~ Aminutes).
4.4.3 Pressure-Reactivity Index (PRx)
The Pressure-Reactivity Index (PRx) incorporates the philosophy of assessing 
cerebrovascular reactions by observing the response of ICP to slow spontaneous 
changes in Arterial Blood Pressure (ABP). When the cerebrovascular bed is nor­
mally reactive, any change in ABP produces an inverse change in cerebral blood 
volume and hence the ICP. When reactivity is disturbed, changes in ABP are 
passively transmitted to ICP. PRx is determined by calculating the correlation co­
efficient between 40 consecutive, time-averaged data points of ICP and ABP [52].
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4.4.4 High-Frequency Centroid (HFC)
The high-frequency centroid is based on evaluation of the power spectrum of a 
single-pulse ICP waveform and calculation of its power-weighted average frequency 
within the range 5 to 15 Hz. The high-frequency centroid was demonstrated to de­
crease with increasing ICP and then increase in the state of refractory intracranial 
hypertension where the blood flow regulation mechanism failed [52].
High-frequency centroid is an integrated measure of non-linear distortion of ICP, 
reported to be inversely proportional to pressure volume index (PVI) in head- 
injured patients. The HFC was initially calculated as the centre of balance (aver­
aged frequency) for power of ICP waveform included within the bandwidth from 4 
to 15 Hz. However, this method of calculation yielded a strong correlation between 
HFC and the heart rate.
Another method for the estimation of HFC was proposed by Berdyga et al. [55]; 
this group estimated HFC from a single selected and standardised pulse waveform 
represented by the series of samples of predefined length. This meant that the 
HFC was expressed as numbers of higher harmonics of ICP waveform rather than 
in Hertz and was therefore theoretically independent of heart rate.
The signal was sampled with a frequency of 50 Hz and divided into sections con­
taining 1024 samples. In each section, the 1024- point fast Fourier transform was 
calculated and the power spectrum density estimated. Heart rate was calculated 
as an inverse of frequency for the fundamental peak of the ICP spectrum. For 
each fragment the mean frequency was calculated for the spectrum within the 
bandwidth from 2.5Hz greater than the calculated heart rate up to 15 Hz. Finally,
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HFC was estimated as the mean frequency divided by the heart rate. HFC can be 
expressed as time-dependent parameter.
4.4.5 True ICP
The product in (4.1) has been suggested to be an indicator of dangerous in­
tracranial hypertension in head injured patients (true ICP). Czosnyka [52] showed 
stronger relationship of the true ICP and patient’s outcome than the relation ICP 
and RAP alone [52].
TrueICp = Meanicp • (1 — RAP) (4.1)
4.4.6 Mean ICP
The mean ICP was computed during 6-second time windows, independently of the 
ICP waveform. The established mean ICP is computed relative to atmospheric 
pressure, not considering whether the ICP signal contains cardiac-beat-induced 
single ICP waves or not [56]. While the mean ICP represents the static pressure 
difference against the atmospheric pressure, the mean ICP wave amplitude reflects 
the dynamic pressure response caused by the intracranial volume (not pressure) 
change induced by every cardiac beat. The mean ICP wave amplitude is highly 
dependent on the intracranial compliance [56].
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4.4.7 Pressure-Volume Compensation or Intracranial 
-Compliance Curve
Theoretically, the compensatory reserve can be studied through the relationship 
between the mean ICP and changes in volume of the intracerebral space, known 
as the pressurevolume curve as in Figure 4.5 [52].
RAP< 0 
D«rang«d 
cerebrovascularICP
rap=i ,e»d,v*yRAP=0
Pulsatile Cerebral Blood
Volume
Figure 4.5: An interpretation of RAP as an index characterizing where the 
cerebrospinal working point rests on the pressure volume curve [52].
The body can cope with an elevated intracranial volume to a certain extent. Once 
this limit is reached, however, a slight increase in intracranial volume leads to a 
severe rise in intracranial pressure. In these circumstances, the patient is said 
to be on the “steep" (uncompliant) portion of the pressure-volume curve as in
Figure 4.6. If unchecked, further pressure rises may lead to compression of the 
brain and eventually life-threatening herniation [57].
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Figure 4.6: Diagram of the intracranial compliance curve, illustrating regions 
of high compliance and tow compliance [51]
The intracranial compliance reflects the relationship between intracranial pressure 
change and volume change, as expressed in the pressure-volume curve. It has 
previously been suggested that the intracranial pulse pressure gives information 
about intracranial compliance since the pulse pressure is the pressure response to 
the change in intracranial blood volume caused by each cardiac beat [58].
4.4.8 ICP Histogram
The histogram is a statistical analysis of the ICP, where pressure measurements 
taken at regular intervals are grouped into pressure classes at standard intervals 
e.g. 5 mmHg as in Figure 4.7. It is found that data did not fit an underlying 
gaussian distribution, and the histogram is skewed to the right, possibly as a 
result of “plateau waves", and that increases in ICP were paralleled by increases
in ICP fluctuation.
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Figure 4.7: Sample ICP histogram recorded over a 24-hour period [59]
4.4.9 Mean ICP Wave Amplitude and Latency
The ICP waveform analysis incorporates an algorithm for identification of the 
cardiac-beat-induced single pressure wave, determining the amplitude (i.e. differ­
ence between beginning diastolic pressure and systolic pressure) and the latency 
(i.e. time interval from beginning of diastolic pressure to systolic pressure) of the 
single ICP waves and then computing the pressure parameters mean ICP wave 
amplitude and latency during subsequent 6-second time windows as in Figure 4.8.
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Figure 4.8: A continuous ICP signal of 30 seconds (left) with a zoomed view 
of single 6-second time window (right) [58].
4.5 Intracranial Pressure (ICP) Signal Features 
Extracted
Analysing the ICP signal included extracting features from the raw ICP data. Ten 
features were selected based on criteria described in [60, 61], these features are 
extracted using a moving time sequence window of 6 seconds then averaged over 
one hour periods. The selected features were also chosen to be computationally 
efficient and have potential for on-line implementation in low-power, implantable 
environments. The ten selected features derived from the ICP for this analysis are 
described below.
4.5.1 Mean
The mean value is already used as a diagnosis parameter by physicians and sur­
geons.
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MeanICp[n] = — ICP[i]
nN
(4.2)
i=(n-l)JV+l
where ICP is the intracranial pressure signal, N is the length of the sliding window, 
i is the discrete time index and n is the slide window number.
4.5.2 Curve Length
The curve length is used for observing changes in amplitude and frequency without 
sensitivity to the measure of self-similarity. The curve length of the signal is the 
sum of the lengths of the line segments between successive samples of a signal. It 
was originally introduced by Olsen in [62] as “line length”, but was later described 
as the “curve length” [63]. The mathematical representation of the curve length 
in its discrete form is
N
(4.3)
i=i
4.5.3 Energy
The energy of the ICP signal shows the position trend and the tendency of the
signal to stay either above or below the baseline, closely related to the signal’s
integral [60, 61]. Considering that a sliding window is used, the energy of the 
signal becomes the average power over the window mathematically defined as
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(4.4)
4.5.4 Nonlinear Energy
The nonlinear energy, also known as Teager energy [60], provides an indication 
about the amplitude and spectral content of the signal, as well as the energy of 
the signal. The nonlinear energy for the ICP signal is represented by
ANEICp[n] = (-ICPW ■ ICPli - 2] + ICP[i - l]2) (4.5)
4.5.5 Katz Fractal Dimension and Hurst Parameter
The Katz fractal dimension and the Hurst parameter measure the long-range de­
pendence of the signal [61]. They can identify whether a signal is becoming non­
stationary, increasing in complexity, or changing its space-filling properties. They 
can show the signals self-similarity, where it is important when looking for pat­
terns that may not be obvious to a human observer. The Katz fractal dimension 
(KFD) is represented as
N log (A" - 1)KFDICp[n\ =
max'AEi V(iCP[i]-ICP[l])W) 
Ei y/(ICP[i+l]-lCP[i}r+l
(4.6)
log( ) + log (A — 1)
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where N is the length of the ICP segment which KFD is calculated over. The 
mathematical representation of the Hurst parameter (H) is
HicpM ~ ln
ICP[i] i 
a (ICP) ~ 2 (4.7)
where a (ICP) is the standard divination of the ICP signal over the N period.
4.5.6 Shannon Entropy and Spectral Entropy
Shannon entropy is a good measure of randomness or uncertainty in the signal 
and it provides indication of the frequency content of the signal [64].
N
ShannonEiCpln] = — (hist(i) • log(hist(i))) (4.8)
where hist(ICP) is the histogram of the ICP signal.
Applying the entropy to the spectrum of the signal is called spectral entropy [65], 
which measures their regularity of the power spectrum of the signal, and represent 
a measure of the distribution of the frequency.
N
SpectralEjcp[n} — -Y^(PSD[{l-log2(PSD\i})) (4.9)
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where PSD is the power spectral density function given by
PSD\i] = 1
NT
TX[i] |2 (4.10)
where T is the sampling period, N is the length of the sliding window and X[z] is 
the discrete fourier transform represented as
N-l
x[i\ - ]T\’[/c]exp 
k=0
—j2irki
N (4.11)
4.5.7 Peak Power and Peak Frequency
Peak frequency and its power represent the frequency of the maximum power and 
that power, where studies show that this frequency represent the heart rate [52]. 
The maximum power is represented as
PeakPower — max(PSD) (4.12)
and the frequency of the maximum power is represented as
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PeakFrequency — index (max (PSD)) (4.13)
4.6 Principal Component Analysis (PCA)
It is advantageous to reduce the number of extracted features and remove the 
redundancy caused by the correlation between the features, to reduce processing 
time and conclude the main representative features. PCA [66] is one of the most 
used multivariate methods, and aims to optimally representing data sets and a 
large number of variables to identify patterns in the data and highlight their dis­
tribution. This method generates a new set of variables (principal components) 
each of which is a linear combination of the original variables. All the principal 
components form an orthogonal basis for the space of the data. The principal com­
ponents calculated of covariance matrix of the extracted feature vectors represent 
a new orthogonal basis which describes the maximum amount of the total variation 
of the original data, and features of less contribution are removed. Optimal cal­
culation is achieved by having the minimum mean-square-error when eliminating 
the least contributing principal components.
The PCA of a set of vectors, i.e. variables, can be calculated based on the 
Karhunen — Loeve Transform (KLT). If X is a matrix of N columns of the ex­
tracted features, and M rows corresponding to an hour’s worth of observations, 
then the zero empirical mean matrix X is computed by subtracting the averaged 
sum of each column x7l from each element of that column. If xn is the vector 
that represents the nth feature of the ten extracted features, the mean vector x is
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formed by taking the averaged sum of xm i.e.
(4.14)
The zero mean vectors are computed as
(4.15)
and the covariance matrix <I> is defined as
(4.16)
where cf>T is the transpose matrix. The eigenvectors v of $ are found by the 
following equation
(4.17)J>Vj = XjVj
where the scalar Xj are the corresponding eigenvalues of $, arranged in decreasing 
order so that Ai > A2 > ...Am- In this way, many of the eigenvectors which 
have corresponding low eigenvalues can be discarded. The reduced number M of 
eigenvectors v — {wi, V2,^m) are the desired weighted coefficients to be applied 
to the original variables. The transformed features x can be reconstructed by 
using the relation
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x = vT(x — a:) (4.18)
The square-error between x and x is given by
SE
M M
= Ev-Ev
J=1 j—l
M
= E
j=M+l
(4.19)
As the error is minimised by selecting the eigenvectors associated with the largest 
eigenvalues, the transformation is optimal in the least-square-error sense. The 10 
extracted features from the ICP traces of 40 patients are analysed using PC A, as 
shown in Figure 4.9, in total, 91% of the variance of the data was found to be 
represented by the first four components of the PCA. So these four components 
are retained and reducing the 10 features into 4 components.
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12 3 4
Principal Component
Figure 4.9: Variance of the data (i.c. 10 extracted features of the ICP traces 
for 40 patients) represented by the first four components of the PCA.
4.7 Interpretation of Principal Components
The first component of the principal component represents 40.5% of the variance of 
the data, its positive part is represented by the spectral entropy of the ICP signal 
(i.e. regularity of its spectrum) and the peak power, while the negative part is 
represented by the Katz fractal dimension and Hurst parameter which measure the 
long dependance of the signal, and the entropy which measures the randomness 
of the amplitude of the signal, as shown in Figure 4.10. The first component 
is thus mainly defined by the regularity (randomness) of the ICP signal. The 
second component represents 26% of the variance of the data, and is represented 
by the energy and the mean value of the ICP signal, as in Figure 4.10. The 
third component represents 15.8% of the variance, and is represented by the curve 
length and the peak frequency as shown in Figure 4.11. The fourth component
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represents 8.3% of the variance and represented by the average non-linear energy 
as in Figure 4.11.
Using the generated components, and projecting the data extracted from the ICP 
traces, it would appear from Figure 4.12 that three clusters of ICP behaviour can 
be identified. If the data used had been descriptive, it might have been possible 
to project the status of the patients on these clusters, describing clusters in terms 
of other physiological parameters. These clusters are best identified by the first 
and the fourth components, Figure 4.12 shows clusters in the first and second 
component, while Figure 4.13 shows clusters from the first and fourth components 
view, where each dot represents one hour average of calculated parameters from 
ICP signal. Referring to the interpretation of components, the first cluster has 
higher irregularity compared to the other two (referring to the first component) 
and less non-linear energy (referring to the fourth component), while the third 
cluster has the highest non-linear energy and the least irregularity.
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e 4.10: ICP features represented in the first and second component of
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Figure 4.11: ICP features represented in the third and fourth component of
the PCA plane
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Figure 4.13: The three clusters as shown from the first and fourth components
of the PCA
Chapter 4. ICP Signal Analysis 71
4.8 Additional Supplementary Variables
Additional supplementary variables can be projected on the generated component 
space, to find the relationship between these variables and the ICP behaviour. 
Figure 4.14 and 4.15 shows the projection of the Gender and Age variables on 
the first and second components. The correlation between the third component 
and the Gender variable is approximately 0.3, which agrees with the manipulated 
data, where cluster 1 has male to female ratio of 1:2 and clusters 2 and 3 have 
male to female ratio of 2:1. This means that the males in this study show higher 
peak power and spectral entropy compared to the females, while females have 
higher Katz FD and Hurst parameter. Also there is a correlation of 0.3 between 
the Gender variable and the third and the fourth components, which means that 
males appear to exhibit higher non-linear energy and peak frequency compared 
to the females. With a correlation of 0.13, between gender variable and the peak 
frequency which corresponds to the heart rate, as shown in Figure 4.15, this is 
expected as heart rate is slightly higher for males than females.
Figure 4.14 represents the projection of the Age supplementary variable on the 
third and fourth components. With the small range of ages among patients (1-20 
years), a good correlation of approximately 0.5 is shown between the Age variable 
and the second, third and fourth component, consistent with visual interpretation 
the data. This suggests that the older the patients are, the higher the non-linear
energy is.
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s 4.14: Age as a supplementary variable is projected on the first and 
second components of the PCA plane
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Figure 4.15: Gender as a supplementary variable is projected on the third 
and fourth components of the PCA plane
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4.9 Conclusions
This chapter has demonstrated the suitability of using PCA for the analysis of ex­
tracted features from ICP signals of patients suffering from hydrocephalus and 
other neological disorders. This study shows the appropriateness of PCA for 
analysing features extracted from ICP signal and highlights the most revealing 
ones. Supplementary variables were added to find the relationship between the 
gender and age variables and the established principal components. Moreover, 
clustering ICP behaviour according to the principal components has been facil­
itated, allowing the characterisation and comparison of subsets of the patient 
population that might otherwise not have been immediately clear.
With the ability of this method to cluster different groups of patients, a more 
elaborate and meaningful classification process can be applied to stratify patients 
into different categories according to perceived risk and improvement. Moreover, 
according to each group, this method can potentially provide an effective way of 
determining suitable parameter settings for programmable shunts used in treat­
ment of hydrocephalus, a process which is currently highly subjective. Further 
studies can be done to investigate the follow up of patients, by acquiring time- 
sequence data for patients and represent as a trajectory in the PCA components, 
these data should include, in addition to the ICP signal, indication about the pa­
tients’ state such as clinical symptoms and other measured values such as blood 
pressure and heart rate. For hydrocephalus patients where valves are implanted 
as paid of shunting systems, other data such as valves settings, can be analysed 
and configured, thus helping in improving these shunts and finding appropriate 
settings for each cluster of patients.
Chapter 5
Intracranial Pressure (ICP) 
Dynamics Model
To be able to evaluate and validate a shunting system for hydrocephalus, a simu­
lation environment of the CSF hydrodynamics is needed. For this purpose several 
ICP dynamics models have been developed to simulate the behavior of the CSF 
hydrodynamics in the skull. These ICP models are an important step in the diag­
nosis and evaluation treatment for hydrocephalus, as in the case of developing an 
intelligent shunts as well as optimising current shunts settings.
The study in this chapter modifies and utilises a patient-specific model of CSF dy­
namics for which the parameters can be optimised. The mathematics behind this 
model is reviewed and its implementation is presented, followed by an illustration 
of parameter estimation and optimisation.
74
Chapter 5. Intracranial Pressure (ICP) Dynamics Model 75
5.1 Mathematical Model of ICP Dynamics
Many mathematical models were developed to simulate the intracranial hydrody­
namics [67, 68, 69, 70, 71, 72], with the purpose of understanding the behaviour 
of the CSF dynamics, and qualitatively predicting the response to a certain ther­
apeutic intervention. These models provided a testing environment and tool that 
help clinicians and researchers assessing treatment plans and procedures. These 
models are implemented utilising different techniques. Some of these were im­
plemented using electrical circuits to mimic the behaviour of the CSF dynamics 
[26, 73, 74], while others make use of control theory [75].
The model used in this research was structured after a model developed by Wake- 
land [76]. This model could accurately reproduce ICP traces from previously 
recorded ones, which could then be used to predict ICP changes in response to 
different treatments. He used the inclination angle of the patient body and the 
respiration rate as treatment options for traumatic brain injury to reduce the 
elevated ICP.
This model was built based on fluid volumes as the primary state variables, rather 
than on pressure as in the most used models. The intracranial pressure ICP is 
calculated based on the total intracranial volume and the pressure volume index 
(PVI):
Pic = PiJ, ■ (5.1)
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where Pic is the ICP, is the baseline ICP, Vtc is the total cranial volume, V\jC is 
the base cranial volume and PVI is the pressure volume index. The PVI, as defined 
by Marmarou [77], is the additional volume needed to cause a 10-fold increase in
ICP.
The total cranial volume Vtc consists of six differential equations representing the 
six volume compartments [76]:
Kc — Pcs/ + Vab + Vvb Vcb + Vtissue + Vh (5.2)
where Vcsj is the volume of the cerebrospinal fluid, Vab is the arterial blood volume, 
VVb is the venous blood volume, Vcb is the capillary blood volume, Vti(3Sue is the 
tissue volume and 14 is the hematoma volume.
As this model is originally designed for traumatic brain injury patients, it takes 
hematoma volume 14 into consideration, which is the volume of the blood collected 
within the tissues and cavities of the brain [78]. For targeting hydrocephalus pa­
tients, this volume is ignored, as there is no bleeding in the case of hydrocephalus.
For hydrocephalus patients, the CSF volume is modelled as in Equation (5.3) [76].
(5.3)
where Fproduced is the CSF production flow rate, Fabsorbed is the CSF absorption
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flow rate through the normal drainage pathways, and Fdrained is the CSF drainage 
flow rate through the artificial drainage route, i.e. the shunt.
While some of the models derived CSF production flow rate as a function of the 
difference between intracranial pressure and the arterial blood pressure, Wakeland 
modelled it as a constant rate as 0.35 mlmin-1, while CSF production is considered 
constant rate of 20 mill-1 subject to variation from 14 to 36 mlh^1 [5, 79]. These 
values are used in this for simulating optimisation of the ICP dynamics model.
The CSF absorbtion flow rate is modelled as in Equabion (5.4):
P—P
i, i ___ %C SS f t* a\
F absorbed = -5------------- (5.4)
■^drainage
where Rdrainage is the CSF resorption resistance and Pss is the difference between 
the systemic venous pressure and the differential intracranial pressure AP due to 
the change in the body inclination angle, as shown in Equations (5.5) and (5.8)
Pas = Pvb - AP (5.5)
AP = d • sin(6) ■ mmHg
mmHiO (5.6)
where AP is the pressure difference, d is the distance between the heart and the 
head, and 0 is the body posture angle, measured from horizontal, while mTn^!Jn is
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a conversion factor.
The Fdrained is the flow rate of the CSF drained through the shunt. This flow rate 
through the shunt depends on the type of the shunt and the valve mechanism. For 
the current passive shunts in use, the majority exhibit a quasi-linear response, i.e. 
nonlinear for only very low flow rates. The shunt drain flow rate can be calculated
by,
0 , Pic < closed valve
(5.7)
Pic > Pth opened valve
where Pth is the pressure at which the valve opens and Rv is the valve resistance. 
This shunt model is for the passive shunts, which in the next chapters will be 
adapted to represent the proposed intelligent shunting technique.
Wakeland [76, 80] has modelled the arterial blood volume according to the follow­
ing relation,
(5.8)
where Fah is the flow rate of the arterial blood and Fcap is the capillary blood flow 
and Fproduced is the CSF production flow rate. The arterial blood Faj} is represented 
in Equation (5.9) [80],
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Fab =
P — PAn. An
Rartery
r3artery
(5.9)
where Rartery is a constant representing artery resistance, Pa is the difference 
between systemic mean value of blood pressure and the AP due to body inclination 
angle as defined in Equation (5.10) and Paic is the pressure in the intracranial 
arteries, where rartery is the arterial radius and defined as in Equation (5.11).
Fa = K.meanJ^BP -AP (5.10)
Tartery — R- * (5.11)
The capillary blood flow Fcap is defined by Equations (5.12) to (5.14),
P ■ — P ■t-i ___ aic cic
" cap —
cap
(5.12)
Reap q ■ Fsm (5.13)
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&m / (5.14)
Ssm is the smooth muscle state, Fcap is the capillary blood flow, is called the 
indicated blood flow and is defined in Equation (5.15), g is the cerebrovascular 
autoregulation gain, RC(ip is the capillary resistance, 7 is a conversion factor.
In Equation (5.14), the smooth muscle state is remained in the range [0,1], where 
’0! represents fully dilated and ’l5 represents max constriction, this is achieved by 
the cubic terms in Equation (5.14). The cerebrovascular autoregulation responds 
to changes in indicated blood flow needs due to diurnal variation, and changes in 
ICP, respiratory rate, arterial blood pressure, and body posture angle.
Where is the indicated blood flow defined by the following Equation (5.15), 
taking the impact of the changing in the actual C02 pressure PaC02 5.16,
/i = A* + a ■ {PaC02 - S) (5.15)
PaC02 - MOV[(k2 -p-VR), tc] (5.16)
where hi is the baseline blood flow, a is the flow multiplier, PaC02 is the actual 
C02 pressure, S is a setpoint due to C02 pressure, MOV (a;, t) is moving average
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of variable x with averaging period t, k2 is offset for C02 pressure, (3 is a conversion 
factor from respiration rate to C02 pressure, VRis respiration rate in breaths per 
minute, tc is the time constant.
The venous volume is defined according to the following relations,
Vvb =
P ■ — P ■1 CIC -1 VIC
R'Vp.n.nn.f;
— Fr dt (5.17)
Fr,
P ■ — P^ VIC -1 s
K (5.18)
where Fcv is the capillary to venous blood flow, PViC and PC7;C are the venous and 
capillary blood pressures respectively, Pss is defined as in Equation (5.5), RVenous 
is the venous radius and K is a constant defined by Equation (5.17)
K =
Rout flow ^resistance
(Rvenous • Vi4)4
(5.19)
The capillary volume is defined according to the relation,
Vcb^ {Fcap — Fcv)dt (5.20)
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Where Fcap is defined in Equation (5.12) and Fcv is defined in Equation (5.18). 
The brain tissue volume Vu88ue is modelled as a constant value by Wakeland [76]. 
Blood pressures are computed from the blood volumes and their compliances:
Pab — Pic + Vab/Cab (5.21)
Pvb Pic + Vvb/Cvb (5.22)
PcB — Pic + Vcb/Ccb (5.23)
where Pic is the intracranial pressure (ICP), Pab, Pvb andPcs are the pressure 
in the intracranial arteries, veins and capillaries respectively, Cab, Cvb and: Cqb 
are the arterial, venous and capillary compliances respectively, VAD, Vvb andWn 
are the arterial, venous and capillary blood volumes respectively.
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5.2 Parameter Estimation
The parameters of this model can be adjusted in an optimisation method with the 
purpose of fitting the simulated ICP generated by the model to the actual ICP 
traces [76]. This optimisation method is performed before shunting and takes use­
ful of the traces that already recorded in the diagnosis stage of the hydrocephalus. 
The ICP dynamics model takes as inputs the time series posture angle and the 
ICP traces measured by posture and pressure sensors, respectively. All the model 
parameters, other than the inputs, are either constants or variables with initial 
values.
The ICP signal computed by the model is compared to the measured one in order 
to determine model fitness for specific sets of parameters values.
The variable sets are of three categories:
• State variables (volumes): these are five variables; three blood volume com­
partments, CSF fluid volumes, and brain tissue volume.
• Inputs variables: the time series of ICP traces and posture angle.
• Other dynamic quantities in the model were parameters being adjusted dur­
ing the model identification process.
The dynamic parameters are estimated based on the measured ICP signal and the 
sensed posture angle. These variables are optimised by keep varying to minimise 
the error square between the ICP traces generated by the model and the measured 
ICP traces. This function in each iteration changes parameter values with the 
purpose of curve fitting the ICP traces.
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5.3 Posture Angle Estimation Algorithm
One main factor that affects the ICP level is the posture angle of the body. The 
arterial pressure and the ICP are changed inversely proportional to the sin of the 
posture angle, as indicated in relation (5.24)
0 f Intracranial arterial and venous pressure i =>■ ICP 4- (5.24)
The ICP model originally takes the posture angle as primary input, however due 
to the lack of the availability of the ICP data annotated by the posture angle, an 
algorithm is designed to estimate the time and the posture angle changes within 
the ICP data. Figure 5.1 shows the steps of the algorithm.
The algorithm takes the ICP signal as an input and extracts the spectral entropy 
which can describe the irregularity, complexity, or unpredictability characteristics 
of a signal. The spectral entropy is normalized between 0 (complete regularity) 
and 1 (maximum irregularity), and is used to quantify regularity and order of 
the power spectrum of the signal, and gives an indication of the overall frequency 
distribution.
The mathematical representation of the spectral entropy is given by:
mN
SE(m) = - P(k) lo§2 P(k)
k=l+(m-l)N
(5.25)
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the estimated time
ICP waveform
Extracting spectral 
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Locating 
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Finding the time of 
the peaks in the 
signal
FIGURE 5.1: Posture angle estimation algorithm diagram.
where P[k] is the power spectral density given as follows:
P[k] = j^\T ■ X[k}\2 (5.26)
and X[k] is the DFT of the ICP signal /CP[n], and is given by:
X[k} = xilCP[n] exp («)
n=0
(5.27)
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where N is the length of the sliding observation window and T is the sampling 
period.
To verify the posture angle estimation algorithm, an annotated sample of ICP with 
posture angle is used taken from the Wakeland database, this sample is shown in 
Figure 5.2. The algorithm takes the actual ICP signal (indicated in Figure 5.2) 
and estimates the times and the posture angle for this sample.
— Actual ICP signal
— Estimated ICP signal
Time (minutes)
Figure 5.2: Sampled data of ICP signal (modelled and observed) annotated
with posture angle [76].
The spectral entropy of the sampled data is extracted as shown in Figure 5.3 which 
shows impulses at the abrupt changes in the ICP level which are correspondent to 
the changes in the posture angle. These changes are determined with a maximum 
determining function, then the corresponding times of these changes are found, as 
shown in Figure 5.4.
Then the ICP signal along with the times of the posture angle changes are fed 
to the optimiser to optimise the ICP model parameters. The estimated times
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Time(mintues)
Figure 5.3: Spectral entropy with detected peaks corresponding to posture
angle changes.
and values of the posture angle changes are shown in Figure 5.5. Comparison of 
the estimated times and values of the posture angle changes from the algorithm 
(Figure 5.5) with times and values measured and recorded during recording the 
ICP signal (Figure 5.2), shows that they are matched to a high degree.
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Figure 5.4: Spectral entropy with clarified peaks.
ICP real signal (observed) 
ICP modelled signal
Time (minutes)
Figure 5.5: Modelled ICP trace compared to the observed ICP trace after 
model parameters optimisation, using posture angle estimation algorithm.
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5.4 Conclusions
In this chapter, an ICP dynamics model is proposed and used to simulate patient’s 
CSF circulation system. The parameters of this ICP model can be optimised to 
reflect patient’s in specific case based on his/ her traces of the ICP. This new 
approach in modelling CSF circulation system gives the opportunity of developing 
and testing new shunting techniques. The optimisation algorithm takes traces of 
ICP annotated by posture angle to optimise the ICP model, however in case of 
unavailability of ICP data measured with posture angle, an algorithm is developed 
to estimate the posture angle times and values changes from the ICP signal itself. 
This model will provide an environment where models of different shunts can 
be tested and optimised. Chapter 6 will give the details of shunt optimisation 
techniques.
Chapter 6
Personalised Settings Optimiser 
for Passive and Mechatronic 
Valves3
In spite of more than 40 years usage of the current passive shunts in managing 
CSF in hydrocephalus patients, and in spite of the new development in the valve 
mechanism as in mechatronic valves, the installation procedure of these valves with 
proper settings lacks the accuracy. The current procedure in selecting the valve 
settings is still determined by the surgeon and the physician experience based on a 
clue from the ICP traces which leads to repeat hospitalisation and shunt revision. 
As intracranial pressure (ICP) is critical for hydrocephalus patients, improper 
shunt valve settings will either increase ICP causing brain damage, or overdrain 
the CSF disrupting the ICP balance. Thus it is important to have a method where 
these valve settings can be chosen properly for each patient so that a normal ICP
3This work has been published in “Personalised Hydrocephalus Shunt Settings Optimiser”, 
1st International Conference on Applied Bionics and Biomechanics. (ICABB-2010), Venice, Italy, 
Oct 2010 [21], and “Personalised Mechatronic Valve Time-Schedule Optimiser for Hydrocephalus 
Shunt”, 1st Middle East Conference on Biomedical Engineering. (MECBME’ll), Sharjah, UAE, 
Feb 2011 [81].
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is preserved, rather than just depending on the surgeon’s experience. This method 
should take the individual patient’s needs into consideration, and based on that, 
the valve settings are tailored for each patient.
In this chapter a new method is proposed to determine optimal settings using 
an ICP dynamics model and ICP traces, so that shunt valves can be configured 
accordingly. This method presents a precise and efficient way for the ICP model 
to be utilised in evaluating the patient’s ICP traces and hence proposing a person­
alised optimal valve settings for each individual patient. These settings could be 
either the opening pressure and flow rate resistance for the current passive valves 
or the time schedule for the new mechatronic valves.
6.1 Introduction
The valve mechanism is simply determined by two parameters; the opening pres­
sure and flow resistance. This mechanism can be defined as a simple equation 
as in (2.2) and represented as in Figure 2.8. Current shunts usually come with 
fixed settings from the manufacturer, fixed pressure and flow resistance. The 
opening pressure of these valves comes in three categories; high-, medium-, and 
low-pressure, such as [33, 35, 82]. In the current procedure of valve settings se­
lection, the opening pressure is initially chosen according to the ICP that was 
measured. Then later on and based on patient’s symptoms, the pressure is either 
reduced or increased non-invasively if programmable valve is used or by shunt re­
vision. If over-drainage symptoms appear, such as headache, the pressure of the 
valve is increased, or if under-drainage symptoms appear, the pressure of the valve 
is reduced. Thus some physicians start with a high value of opening pressure and
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according to the patients’ feedback,the opening pressure is reduced. While others 
prefer to start with a low value of the opening pressure, and increasing it based 
on the response from the patient. This procedure causes patients suffering, as this 
procedure depends on rough estimation which may not properly drain the proper 
CSF volume. This means that over-drainage or under-drainage is still expected. 
Therefore, care must be taken when lowering or increasing the valve pressure. So 
which valve settings to chose and on what bases, are still the challenging questions 
for the physicians. Starting with low or high pressure settings is investigated by a 
study performed by Boon et al. [83]. This study compared low versus high pressure 
shunt outcomes in 96 patients. The comparable results between the two groups 
of patients were insignificant, while the authors suggested for normal pressure 
hydrocephalus low pressure valves should be used.
Another type of valve was introduced, such as the adjustable Codman Hakim 
programmable valve [84, 85]. This type of valve introduced the possibility of 
non-invasively adjusting the opening valve pressure. This valve is analysed in 
comparison with the standard Hakim valves in 400 patients [86], covering valve- 
related complications and shunt revisions. The advantages of the programmable 
valves were not clinically significant, where the study concluded that it is still 
justified to implant standard Hakim valves in adult hydrocephalus patients. Even 
with this latest advances in valve technology, which allow non-invasive adjustment 
of the pressure settings, the current criteria for selection of the valve opening 
pressures is not well-defined and still not efficient and not patient specific [8].
Recent development in hydrocephalus valves is the invention of a mechatronic 
valve. It is directed toward the usage of electrical control system. This valve 
was first developed by Miethke [13] in 2005, and uses an electric actuating system
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to control the opening and closing the valve. This valve gives a new option for 
hydrocephalus shunts that is aiming to treat hydrocephalus not only controlling 
it, by reducing the shunt dependency [14]. The actuating controlling system of 
the mechatronic valve is driven by software program which regulates the opening 
and closing of the valve. This valve can be configured in two cases. In the first 
case, the valve uses a schedule program such as the schedule used by Miethke [13]. 
This schedule is simply a times of opening and closing of the valve during the 
full day. This schedule is repeated everyday. While in the second case, the valve 
is to be connected with a pressure sensor. The valve in this case opens and 
closes according to the perceived ICP and relative to the acceptable ICP levels 
determined before shunt installation. The idea of using the a pressure sensor 
is already used in telemetry systems to monitor the ICP to evaluate the shunt 
functionality [87, 88, 89]. Where using the ICP sensor to instantaneously and 
autonomously regulate the valve opening and closing times is not yet available. 
Thus the current efficiency of this valve depends on the selection of a suitable 
valve schedule that suit each patient. However, instantiating appropriate valve 
time schedule is still a problem in implementation and utilisation of such a valve. 
This is due to the dynamic behaviour of intracranial pressure that not only varies 
among patients but also within the individual patient with time. This schedule 
could be dynamic relating to certain measurable signal, such as the mean value of 
intracranial pressure over certain period, in this case the proposed time schedule 
is flexible and responds to the dynamic behaviour of the CSF.
A shunt is said to be functioning properly if it is draining at an appropriate rate and 
maintaining an acceptable level of ICP. While inappropriate opening pressure set­
tings always results in incorrect drainage either under-drainage where insufficient 
CSF is drained from the ventricles which keeps the ICP high and hydrocephalus
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symptoms, or over-drainage where a higher volume of CSF is drained than required 
which disrupts the ICP balance causing bleeding. So the current procedure in se­
lecting the valve settings shows that there is a necessity for a method to customise 
the valve settings to fit the patients’s needs.
6.2 Mechatronic Valve Structure
The mechatronic valve takes the shape of a ball situated by a spring, and actuated 
by a coil that is energised by a battery. If the valve is in closed position, then the 
ball is resting in a sealing manner on a valve aperture, while in open position, the 
ball recesses aside adjacent to the valve aperture. Figure 6.1 shows cross sectional 
view of the valve structure [13]. The ball in this shunt is fabricated from a light 
material such as aluminum oxide ceramic, and is has a diameter larger than the 
diameter of the hole of the valve outlet. The valve is closed if the ball is enforced 
against the hole preventing more drainage. In the open position, the ball is pushed 
aside from the hole, allowing fluid to drain. The electric system which controlling 
the valve is powered by a battery. It energizes a coil by a current. The coil in turn 
generates a magnetic field that could attract or release a slide allowing the ball 
to be moved between two positions, which closes or opens the valve. The ball in 
the other side is supported by a spring. Furthermore, the spring could secure the 
position of the ball in vibrations cases. The valve is ending with an outlet that 
drain the fluid through its hole and fitted with a drainage tube.
The slide of the valve through the coil is controlled by time schedule. This time 
schedule determines the opening and closing times and periods. This valve control 
mechanism is subjective to many drawbacks such as the improper drainage, i.e.
Chapter 6. Settings Optimiser for Passive and Mechatronic Valves 95
Electronic
Battwy sy,,,
OOOOOOl
looooooopooooT
Slide Valve T Bllnde 
Outlet Hole
Figure 6.1: A sectional view of a bi-stable mechatronic valve.
over/under-drainage, if improper time schedule is installed. In order to optimise 
the efficiency of this valve, the time schedule should be carefully and accurately 
selected and tailored to satisfy the individual patient needs. Personalise the time 
schedule for each patient is impossible work based on the current procedures in 
installing even the old fashioned valves. Taking also the variation in the dynamic 
behaviour of the intracranial patient with time.
An optimiser system to optimise the time schedule for the mechatronic valve is 
proposed in the coming sections. This optimiser benefits from the patient’s own 
data to personalise an optimum time schedule for that patient in specific.
6.3 Proposed Shunt Settings Optimiser
The studies carried out, on both the passive and mechatronic valves, reveal the 
need for a procedure that can customise the settings of a valve to the clinical needs
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of a patient who needs the hydrocephalus shunt. The method proposed in this 
chapter achieves personalised shunt settings, tailored for each specific patient.
The proposed optimiser uses a pre-recording of the ICP to determine the CSF 
circulation parameters of the patient’s state. This specific measurement of the 
ICP and in turn the dynamic CSF behaviour can be used to determine either 
the valve opening pressure and flow rate resistance for passive valves or the time 
schedule of the mechatronic valve. These valve parameters are adjusted using an 
optimisation technique with the ICP model to optimise the shunt functionality 
and satisfy the specific patient’s needs.
The optimiser performs the work in two steps: the first step is to determine the 
hydrodynamics parameters of the CSF system of the patient, the second step is to 
optimise the shunt functionality based on this characterisation. Figure 6.2 shows 
a block diagram of the valve settings optimiser system.
6.3.1 Characterising Patient’s Cerebrospinal Fluid System
The proposed optimiser uses the ICP model introduced in Chapter 5, to char­
acterise and estimate the hydrodynamics parameters of the unshunted patient’s 
cerebrospinal circulation system. The optimiser uses 30 minutes traces of the ICP 
signal which are recorded during the diagnosis period at a sampling rate of 100Hz. 
These ICP traces are annotated with the body posture angle, otherwise these ICP 
traces are used to estimate also the posture angle as proposed in the algorithm in 
Section 5.3. The ICP dynamics patient’s model parameters that optimised include 
base cranial volume, absorbed CSF, produced CSF, and the inclination angle of 
the posture.
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Figure 6.2: Shunt Settings Optimiser: Patient’s model parameter characteri­
sation and shunt parameters optimiser, for passive and mechatronic valves.
The shunt model optimiser adjusts the parameters of the ICP model to minimise 
the error between the real ICP traces of the patient for whom the model is person­
alised and the simulated ICP traces generated by the model. The primary input to 
the optimiser is just the real ICP traces recorded prior to the insertion or revision 
of the shunt. These traces were fed to the optimiser after being smoothed by a low 
pass filter to remove most high frequency components above 10 Hz and to keep 
the behaviour of the mean ICP.
Figure 6.3 shows real ICP trace of a non-shunted hydrocephalus patient and the
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corresponding modulated (estimated) ICP trace, and an estimation of the posture 
angle. This angle of the body affects heavily the ICP level, and the estimated 
angles shown in the figure imitate the actual angle of the patient body when lying 
on the bed with an approximate angle of around 30 to 70 degrees. At the same time 
the specific parameters of the model were determined, such as the CSF production 
and absorption. The CSF production is considered constant rate of 20 mlh-1 
subject to variation from 14 to SOmlh-1 [5], while CSF absorption is believed 
to be talcing place through distinct pathways, it is represented in the model as 
CSF drainage resistance. Another real ICP trace of 11.5 hours for hydrocephalus 
patient is shown in Figure 6.9 and used to optimise the mechatronic valve time 
schedule.
6.3.2 Differential Pressure Shunt Settings Optimiser
The shunt settings optimiser fixes the estimated parameters of the model and 
optimises the opening pressure threshold and resistance of the shunt, based on 
another input which is the target ICP level recommended by the surgeon and the 
physician (for healthy people, this is typically in the range of 7-13 mmHg [5], where 
a mean value of 10 mmHg is chosen). The shunt settings optimiser is evaluated in 
three different scenarios. Firstly it is set to optimise both opening pressure and 
resistance values, secondly it is set to optimise the shunt opening pressure only 
with fixed resistance values, and thirdly, it is set to optimise the shunt resistance 
only with fixed opening pressure values. This shows the flexibility of this system, 
if it is to be used to choose among different commercial valves with preset opening 
pressure and resistance values. Figures 6.3-6.8 show the resultant ICP level for
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the different scenarios based on the patient’s optimised model configured in the 
previous stage and the recommended normal ICP which is chosen to be 10 mmHg.
6.3.3 Mechatronic Shunt Settings Optimiser
The shunt optimiser utilises the patient model parameters optimised in the pre­
vious stage and then optimises the time schedule of the shunt. The optimised 
parameters of the time schedule are the period P and the duty cycle r which 
determines the percentage opening period during the total period.
The shunt settings optimiser utilises the characterised model in the first stage to 
optimise the period and duty cycle of the time schedule. The optimiser gives the 
physician the option to select the desired normal ICP level. The recommended 
levels of the ICP are in the range of 7-13 mmHg as indicated by [5]. Figure 6.10 
shows the resultant ICP based on the model configured in the previous stage and 
the recommended normal ICP which is chosen to be 7 mmHg. Figure 6.11 shows 
the mean value of the ICP trace before shunting and the mean ICP after shunting 
with optimised parameters in two cases. The first one is for the mean ICP after 
shunting with traces represent the ICP 7 mmHg is the recommended ICP value 
was fed to the shunt optimiser which represent the lower limit. In the second case 
the recommended ICP value was the 13 mmHg which represent the upper limit of 
the recommended ICP. It is clear from the figure that the ICP after shunting is 
kept constant and within the accepted normal limits.
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6.4 Results
6.4.1 Results of Optimised Differential Pressure Settings
The optimise!' system proposed in this work is tested for real ICP trace of un- 
shunted hydrocephalus patient, shown in Figure 6.3. The mean ICP is measured 
over 30 minutes of ICP interval without shunt which is found to be 15.8mmHg, 
and the modulated (simulated) mean ICP which is found to be 16.2mmHg, and 
this trace is annotated by the posture angle. Figure 6.3 shows how accurately the 
optimise!’ can estimate the model parameters to fit accurately the simulated ICP 
to the real ICP.
Three different scenarios are tested, where the first scenario takes both valve open­
ing pressure and resistance as variable parameters, while the second scenario con­
siders the opening pressure as the only variable parameter, and the third scenario 
considers the resistance as the only variable. Figure 6.4 shows the ICP traces of 
the first scenario, which shows the modulated ICP with acceptable mean value 
(10.5mmHg) compared to the recommended normal value which is lOmmHg, after 
configuring the shunt with the optimal values opening pressure (Pth) of 1.03mmHg 
and valve flow resistance (Rv) of 32.3mmHg/ml/min. Figure 6.5 and 6.7 show the 
output traces of the ICP after configuring only the opening pressure with fixed 
resistance (Rv) of 6 and lOmmHg/ml/min respectively. The resultant mean ICP 
of each case are 12.3mmHg and ll.SmmHg with optimal opening pressure values 
(Pth) of 14.9 and 13.2mmHg respectively. The last case is simulated in Figure 6.6 
and 6.8 with variable resistance and fixed opening pressure (Pth) of 0 and 4.5mmHg 
respectively. The optimal resistances for the last case are found to be 33.5 and 
27.7mmHg/ml/min with resultant mean ICP of 10.5 and 10.6mmHg respectively.
Chapter 6. Settings Optimiser for Passive and Mechatronic Valves 101
Table 6.1: Optimal valve hydrodynamic parameters using the proposed opti­
miser with the resultant mean ICP, where fixed values are in shaded cells.
Opening Pressure 
[mmHg]
Hydrodynamic resistance 
[mmHg/ml/min]
Resultant mean ICP 
[mmHg]
1.0 10.8 10.5
14.9 2.0 12.3
13.2 3.3 11.3
0 11.2 10.5
4.5 9.2 10.6
Table 6.2: Basic hydrodynamic parameters of a number of valves [90].
Valve type Opening Pressure Hydrodynamic resistance
[mmHg] [mmHg/ml/min]
1.5T0.5 1.7±0.6
4.2±0.7 1.7±0.6
Starta 6.1T0.9 1.7±0.6
8.4±1.5 1.7±0.6
10.7±0.8 1.74=0.6
7.0±0.6 2.2T0.8
9.5T0.4 2.2±0.8
DSV 12±1.1 2.2±0.8
22±2.1 2.2±0.8
28T1.9 2.2±0.8
38±2.2 2.2±0.8
SinuShunt 2.5T0.5 9.6T0.96
Table 6.1 shows the optimum settings from different scenarios. It is clear that 
with the optimum setting the mean ICP is preserved around the targeted value of 
lOmmHg. Comparing these optimised settings with the commercial values lised in 
Table 6.2, it is shown that the optimised values lay within the commercial values, 
so this method gives an easy way of which valve settings to choose.
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Figure 6.3: Characterisation of the unshimted hydrocephalus patient model 
over 30 minutes; the actual mean ICP is 15.8 mmHg and the modulated mean
is 16.2 mmHg.
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Figure 6.4: Resultant mean ICP of 10.5 mmHg after shunt Optimisation, with 
optimum opening pressure Pth = 1.0 mmHg and optimum resistance value Rv=
10.8 mmHg/ml/min.
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Figure 6.5: Resultant mean ICP of 12.3 mmHg after shunt Optimisation, with 
optimum opening pressure Pth = 14.9 mmHg and fixed resistance value Rv=
6 mmHg/ml/min.
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Figure 6.6: Resultant mean ICP of 10.5 mmHg after shunt Optimisation, with 
optimum resistance value Rv= 11.2 mmHg/ml/min and fixed opening pressure
Pth = 0 mmHg.
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Figure 6.7: Resultant mean ICP of 11.3 mmHg after shunt Optimisation, with 
optimum opening pressure Pth = 13.2 mmHg and fixed resistance value Rv=
10 mmHg/ml/min.
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Figure 6.8: Resultant mean ICP of 10.6 mmHg after shunt Optimisation, with 
optimum resistance value Rv= 9.2 mmHg/ml/min and fixed opening pressure
Pth = 4.5 mmHg.
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6.4.2 Results of Optimised Mechatronic Settings
The optimiser system proposed for the mechatronic valve was tested for a period 
of 11.5 hours for real ICP trace of an unshimted hydrocephalus patient. The ICP 
trace is divided into segments each of which is of 10 minutes duration. These 
segments are fed to the patient’s model optimiser to optimise the parameters of 
the model. Figure 6.9 shows accurately the optimiser can estimate the parameters 
of the model to fit the simulated ICP trace to the real ICP trace.
Then these parameters are fixed in the shunt parameters optimiser while it op­
timises the shunt parameters. For this simulation, the shunt parameters are re­
stricted to the duty cycle while the period and the valve resistance are fixed. The 
period is fixed to the one third of the 10 minutes (i.e. 3.33 minutes), and the 
valve resistance is fixed to 1 mmlig/ml/min. Figure 6.10 shows the simulated ICP 
based on the optimised parameters of both the patient’s model and the optimum 
shunt parameters, which to good extent keeps the ICP within the normal range.
To find the range that the duty cycle can go within, the shunt optimiser optimises 
the shunt parameters (i.e. duty cycle) in two cases of optimisation. In the first one 
the shunt optimiser assumes the recommended normal ICP to be 13 mniHg which 
is considered the upper limit for ICP, and in the second case of optimisation, the 
shunt optimiser assumes 7 mmHg as the lower limit for the recommended ICP. 
Figure 6.11 shows the mean value of the real ICP, and the simulated ICP after 
shunt parameters optimisation for both cases lower and upper limits. As shown 
from the Figure 6.11, the optimiser successfully preserved the ICP fairly constant 
for both the lower or the upper limit.
In this work, the duty cycle is found as a relation to the mean value of the measured
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ICP as shown in Figure 6.12. This duty cycle value is the average values of both 
the lower and the upper limits simulated in Figure 6.11. The best linear fitting 
relating the duty cycle (r) to the mean value of the measured ICP is shown in 
Equation (6.1). This relation shows that the duty cycle, which represents the ratio 
of the opening duration to the total period 3.33 min, is directly proportional to 
the unshunted mean ICP.
r = 0.72 • ICP - 2.1 (6.1)
As the posture angle of the body is heavily affecting the ICP level in an inverse 
relationship [76], another important relation is found relating the shunt duty cycle 
to the body angle, as shown in Figure 6.12 and indicated in Equation (6.2). This 
relation agreed with the pervious relation as the ICP and the posture angle 0 are 
inversely proportional.
r — —0.41 -0 + 25 (6.2)
Since shunt dynamics parameters must be configured by a trained physician and 
carried a risk of inaccuracy, it is therefore highly desirable to develop a system 
that can configure the shunt settings based on the patient’s needs, and taking the 
patient’s cerebrospinal hydrodynamics system into consideration.
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Figure 6.9: Characterisation of the patient model, showing 11.5 hours of the 
real ICP trace and the simulated ICP trace generated by the model optimiser. 
The blue trace represents real ICP reading and the red trace represents, the 
model’s ICP output after optimisation of parameters.
ICP before shunting mean value 
—ICP modeled after shunting lower limit - 
ICP modeled after shunting upper limit
-10 -
Time (hours)
Figure 6.10: Mean value of the real ICP trace and the simulated ICP traces af­
ter patient model and shunt parameters optimisation. The blue trace represents 
the average value of the real ICP and the green and red traces represent the 
upper and lower values of model’s ICP output after optimisation for 13 mmHg 
and 7 mmHg recommended ICP respectively.
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Figure 6.11: Relationship between the duty cycle (r) and the mean value of 
measured ICP; r = 0.72 • ICP — 2.1.
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— Best linear fitting y = - 0.41*x + 25
Posture angle (degree)
Figure 6.12: relationship between the duty cycle (r) and the body inclination
angle; r = —0.41 -0 + 25.
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6.5 Conclusions
This chapter has demonstrated the suitability of using the TCP Dynamic Model 
in proposing suitable shunt settings based on a single hydrocephalus patient. Al­
though this method is not verified by long periods of ICP traces and large number 
of patients, due to lack of data available, this work shows the appropriateness of 
this method in developing such a system which will save time and effort by giv­
ing accurate and efficient way configure shunt parameters personalised to specific 
patient.
ICP dynamics model has been used with diagnostic ICP traces to optimise shunt 
dynamic parameters, ICP opening threshold (Pth) and flow resistance (Rv). The 
model can be optimised to reflect patient status in specific through being fed 
by that patient ICP traces when the hydrocephalus was diagnosed. This will 
let the shunt parameters to be configured according to patient status taking into 
consideration the patient’s normal drainage pathways, as the shunt settings should 
not be over estimated which in this case will weaken the normal pathways and let 
them depend fully on the artificial drainage system through the shunt. Since 
shunt dynamics parameters must be configured by a trained physician and carried 
a risk of inaccuracy, it is therefore highly desirable to develop a system that can 
automatically configure and tailor shunt parameters.
The same optimiser is implemented to optimise the time schedule parameters 
for the mechatronic valve. The optimised duty cycle of the schedule is found 
as a relation of the mean ICP. It is noticed that the mean ICP with the shunt 
parameters optimsed (i.e. duty cycle) is kept within the normal ICP ranges. 
Further work can be done to investigate long time series of ICP and evaluating
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the time schedule of the shunt based on the CSF production and absorption cycle 
of the patient during the day. This will give the shunt more precise values, and 
eventually permits the removal of the sensors, while the opening period becomes 
stable and depending on the day time, reflecting the CSF production cycle.
Chapter 7
Intelligent Hydrocephalus Shunt 
for Reducing Shunt Dependency4
The dominant treatment for hydrocephalus is to divert the excess CSF from the 
ventricles in the brain to another part of the body by means of an implanted shunt. 
While this treatment saves the lives of many hydrocephalus patients, it is clear 
that total shunt dependency, with all its problems and shortcomings, is a common 
unsatisfactory consequence. This, in addition to that the increasing numbers of 
patients suffering from this disease, and the associated costs of their treatment 
have together highlighted the deficiencies of the current modes of treatment, and 
have stimulated research towards the next generation of hydrocephalus shunts. 
What is beginning to emerge is a totally new approach towards the treatment and 
management of the disease. This approach responds to the needs of individual 
patients in an autonomous way.
Based on this fact, an approach is proposed in this chapter to reduce shunt de-
4TMs work has been published as “Intelligent Shunt Agent for Gradual Shunt Removal”, in 
Proceedings of the IEEE Eng Med Biol Soc. (EMBC), Buenos Aires, Argentina, pp. 430-433, 
Sep 2010. [22]
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pendency “weaning” and arresting hydrocephalus by increasing the efficiency of 
the normal absorption paths of the cerebrospinal fluid. This approach attempts to 
gradually reduce shunt dependency while it is satisfying the patient continuously 
by keeping the ICP within the normal ranges thus minimising risks.
7.1 Introduction
As most shunted patients have their natural drainage pathways still functioning 
to a certain limit which means partially dependent on the shunt, this motivates 
the needs to have the shunt design address this shunt independence gradually with 
the aim of reducing shunt dependency. This will modify the functionality of the 
shunt from just managing hydrocephalus only to the attempt of treating it.
Shunt removal has been initially considered by physicians when they noticed hy­
drocephalus patient naturally recovered while their shunts out of functionality 
due to different reasons such as shunt blockage or catheter and tube disconnec­
tion [91]. The researchers and clinicians try to find methods to identify and detect 
such shunt independence to help in making a decision of the opportunity of shunt 
removal. One of the attempts the physician used is that they try to control the 
opening and closing periods of the valve through an adjustable opening pressure 
valve and monitoring the ICP and the symptoms of the patients. As this method 
shows clear patients classification regarding their ability to be shunt independent, 
this method includes long term of patient’s monitoring and it depends on rough 
evaluation of the patient’s status progress. Managing this process totally by the 
shunt and using accurate indications of the progress in the patient’s status while
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reducing the risks accompanied by this process, is the targeted methodology in 
this work.
7.1.1 Shunt Dependency Detection
Shunt dependency detection started from the detection of shunt functionality. 
Shunt functionality is detected through measurements of of the flow rate of CSF 
through the shunt. Different methods were used to measure the CSF flow rate. 
These include thermometric measurement [92] and valvography [93], while the 
most used method is the implantation of a CSF flow measurement device [94], 
Other methods [95] used in detecting shunt dependency is based on determination 
of the flow resistance of the natural absorption pathways. These measurements 
imply infusion of a fluid inside the subarachnoid with the valve is closed and 
measuring the ICP.
7.1.2 Shunt Removal Attempts
Shunt removal is attempted through gradual increase of ICP which could stimulate 
the natural absorption pathways. This procedure is performed by Takahashi [16], 
as he increased the ICP into steps through adjusting a programmable valve. He 
noticed that if the patient has not developed symptoms of increased ICP or ventric- 
ular enlargement, then this gives good opportunity of shunt removal. He succeeded 
in removing shunts from more than 50% of the 100 patients over 2 years. While 
this procedure requires long observation and follow-up periods, it demonstrates the 
success of this method [96]. Other similar studies adopted the gradual increase in
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ICP as procedure which could lead to activation of natural absorption pathways 
was also adopted and applied on cats [15].
7.2 Shunt Removal Motivation
It is reported that it is unnecessary to remove more than one-third of the produced 
CSF volume a day [15], where there is part of the CSF which normally drained 
through the normal absorption system. This verifies the belief that the normal 
absorption pathways continue to function to a certain limit in most cases of hy­
drocephalus. In this case, shunting causes the normal drainage system to rely on 
the artificial drainage systems and does not allow the skull and the absorption 
system accommodate properly to the CSF being produced. Therefore the next 
shunt designs and treatment plans should not only be directed toward satisfying 
patient instantaneously by keeping the ICP within the normal values, but also to 
enhance the effectiveness of the normal absorption system in the long term. This 
can be achieved by using a mechatronic shunt incorporating a kind of intelligence 
and equipped with a pressure sensor. This proposed system gradually deliberates 
and controls the opening pressure of the valve. The aim of such a shunting tech­
nique is to keep the ICP within normal levels, while at the same time stimulating 
the normal absorption pathways. Thus by pursuing these two goals at the same 
time, eliminates any risks associated with reducing shunt dependency procedure. 
However, if it is clear’ that shunt dependency is unavoidable then this intelligent 
shunt can optimise shunt settings for patient’s needs.
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7.2.1 Estimating the Shunt Dependance
Estimating the level of a patient’s dependency on the shunt and evaluating his/her 
progress in case of reducing shunt dependency are important issues in initiating a 
weaning plan. Integrating this capability in the shunt would enable it to adapt to 
the patient’s needs, as the normal paths of the natural drainage system are still 
functioning to a certain extent and this varies from patient to another according 
to the patient’s status. Some shunts are fitted with on-off valves or other devices 
to regulate the drainage of CSF, however they lack the capability capability in 
evaluating patient’s shunt dependency. This deficiency in current shunt could 
highly turns patients with partially functioning natural drainage system to a fully 
dependent on shunt and letting the patient’s cranial drainage system rely on the 
artificial drainage system. If the patient is found to be partially dependent and 
could be weaned off the shunt, this would avoid him/her problems resulting from 
shunts which have complications.
An intelligent agent utilising ICP model will be integrated in the shunt to estimate 
the level of shunt dependency and the progress in reducing shunt dependency. This 
agent estimates virous CSF circulation parameters in ICP model based on mea­
sured traces of ICP signal, as proposed in Chapter 6. Based on these parameters, 
the agent will estimate the level of shunt dependency. Periodically estimating these 
parameters and evaluating shunt dependency with time progress gives a method 
in evaluating the progress in reducing shunt dependence plan.
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7.2.2 Reducing the Shunt Dependence
As the intelligent shunt agent detects and estimates the shunt dependence and 
while it is satisfying the patient by keeping the ICP within the normal range, it 
initiates a careful weaning plan. It starts increasing the ICP level in cautious 
steps while monitoring the ICP and evaluating the natural drainage pathways 
response. Natural drainage pathways response could be evaluated through periodic 
estimation of the absorbed CSF flow rate. Using implanted ICP sensor with the 
shunt will enable the shunt agent to control the level of the ICP and monitor the 
weaning process effectively.
The shunt agent and by using ICP model, evaluates the CSF system response 
to the higher ICP pressure, and the ability of the natural drainage pathway to 
drain more CSF volumes. This shunting technique compared with other “manual” 
weaning trials enables efficient detecting, monitoring and evaluating of the different 
stages of the weaning process without invasive shunt removal process depending 
on same diagnosing methods in evaluating the process results. In case that the 
patient is fully dependent on the shunt and the shunt is unavoidable, the shunt 
is already installed controlling the ICP level thus avoiding any risk. Controlling 
of ICP in case of shunt dependent patient is to keep the normal level of the ICP 
while working as a closed loop system and optimising the valve settings to fit the 
patient’s needs.
7.2.3 Proposed Shunt Features
The proposed shunting system will provide a self monitoring and evaluation of pa­
tients’ status. Monitoring the ICP signal through the pressure sensor will provide
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a long term of observation which reduce risk. While the patient is out of surgeons’ 
observation. Evaluation of patients current state through monitoring the ICP and 
estimating the CSF circulation parameters will provide more accurate method of 
evaluation patient’s status, either in the short term when managing the ICP to be 
in the normal range while removing high pressure symptoms, or in the long term 
when the patient under goes a treatment plan to reduce shunt dependency.
7.2.4 Utilising Self-Learning Agent
As documented in the last section, the proposed shunting system should deliver 
both reactive solutions for hydrocephalus management and goal-driven solutions 
for the treatment, at the same time monitor the performance of the shunt and 
patients’ status progress. These tasks can be achieved by implementing an agent 
approach in designing this system. Such an agent system would help to understand 
more about the dynamics of hydrocephalus. For this agent to be autonomous, it 
should learn what to do and how to control the valve by itself and should discover 
which pressure level and weaning plan that yields the most reward, through direct 
interaction with the patient’s environment (i.e CSF circulation system). This 
could be achieved by using a reinforcement learning agent.
7.2.4.1 Reinforcement Learning Agent
Reinforcement learning agent is a computational agent that understands and 
utilises a learning and decision-making method to pursue a specific goal. It differs 
from other learning approaches as it concentrates on learning individually from 
direct interaction with the environment. Reinforcement learning uses term states,
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actions, and rewards to represent the framework of the interaction between the 
learning agent and the environment. This framework represents the structure of 
a simple artificial intelligence learning system.
The reinforcement learning consists of four main elements; policy, a reward func­
tion, a value function, and optionally, a model of the environment [97].
A policy defines the learning way of the agent. It maps the perceived states of the 
environment to actions to be taken while the agent is in those states. The policy 
varies from a simple function or look-up table to extensive computation such as 
search processes. The policy represents the core of the reinforcement learning 
agent as it determines the behaviour of the agent.
A reward function defines the goal in the reinforcement learning process. It maps 
each sensed state to a single number, a reward, representing the desirability of 
that state. So the agent’s objective through the learning process is to maximise 
the total reward in the long run. The reward defines how good or bad the action 
taken by the agent is and whether the process has become better or worse than 
before.
A value function specifies what is good in the long run while the reward function 
indicates what is good in an immediate sense. The value of a state is the total 
amount of reward an agent can expect to accumulate over the future starting from 
that state. Actions are chosen based on value function, looking for actions that 
lead to states of highest value, not highest reward, because these actions obtained 
the greatest amount of reward in the long term.
The model is a structure that mimics the behaviour of the environment. It can
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predict the next state and next reward. Models are used for planning, by consider­
ing future situations before they actually happened. In this work, models are used 
in different aspect, as the adopted method, explained in section 7.2.4.2, does not 
need model for planning. So the model, i.e. ICP model, is used in the evaluation 
of the reward.
7.2.4.2 Actor-Critic Method
One of the algorithms used in implementing reinforcement learning agent is Actor- 
Critic method, which is used in this work. The Actor-Critic method uses two 
main structures with separate memories. The first structure is the policy struc­
ture which is called the actor, that is used to select actions. The second structure 
is the estimated value function which is called the critic, that criticises the ac­
tions made by the Actor. The Critic must learn about and critique whatever 
policy is currently being followed by the Actor. This is applicable to the proposed 
shunt, which should have the ability to take the proper action and then observe 
the gained reward which in turn either enforces the current plan of treatment and 
management or motivates a change in the current plan, and that is what the Critic 
function provides. The Critic function is based on the temporal difference (TD) 
error, which the difference between value function of successive time steps states, 
as shown in Equation (7.1). Figure 7.1 shows the Actor-Critic structure.
The Actor according to this agent selects an action, then the Critic evaluates the 
new state to determine whether things have become better or worse than expected 
based on the TD error, as shown in Equation (7.1).
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Figure 7.1: Actor-Critic architecture [97]
8t = rt+i + iVist+i) - V(st) (7.1)
where V is the current value function of the current and the previous states, 7 is 
a discount rate which determine the present value of the future states, and rt+i 
represents the reward from the current action taken.
If TD error (<5*) is positive then that means the current selected action should be 
strengthened and recommended for the future, while negative 8t means that this 
action should be weakened.
The actions in the learning method are generated by policy, and one of the policies 
followed is the Gibbs softmax as indicated in Equation (7.2),
Chapter 7. Intelligent Shunt for Reducing Shunt Dependency 121
eP(s,a)
7rt(s, a) = Pr{at = a|s* = s} = ^ ep(sb) (7.2)
p(s, a) is the value at time t of the modifiable policy parameters of the Actor, 
which is the probability (be. preference) of selecting action a when in state s. Then 
according to Critic function this action a can strengthen or weaken by increasing 
or decreasing the p(s, a), as in Equation (7.3);
P(st, at) P{st) ct>t) + (7.3)
where /? is a step-size parameter.
This reinforcement learning method, i.e Actor-Critic method, has main two advan­
tages which makes it an attractive method. First, it requires minimal computation 
in selecting actions. Second, it can learn a stochastic policy, i.e. it can learn the 
optimal probabilities of selecting various actions.
7.2.4.3 Applicability of Act or-Critic Method in the Proposed Shunt
The structure and the behaviour of the Actor-Critic method give the opportunity 
to be used as a controlling method in the new shunting system. All the require­
ments of self-learning and goal driven shunt components can be achieved by this 
method. The action can be chosen from a set of actions based on its success in 
achieving good reward. This can be the decision maker of the shunt as to which
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action to take to control the valve on/off switching and which ICP pressure to 
preserve. The CSF circulation system compliance and patient’s status progress 
can be assessed by evaluating the reward from the current action being taken. 
Evaluating the reward of the action being taken is based on estimating the CSF 
production and absorption flow rate which can give indication of how better or 
worse the current action is.
In this method, certain action can be enforced or weakened by modifying the dis­
count rate of that action or the step-size parameter as indicated in Section 7.2,4.2. 
This option gives the opportunity of enforcing certain action to occur, i.e. cer­
tain ICP pressure to be preserved, irrespective of its actual reward. This may be 
needed in stimulating the natural drainage pathways which may get low reward 
at the beginning.
As this needs to be applied in a critical situation, i.e. medical application, actions 
should be selected carefully to avoid any risk. So this method should be modified 
to take this into consideration. The action selection criteria in the Actor-Critic is 
based on the exploration and exploitation of the actions. This means selecting an 
action is based on probability and the reward from that action either to enforce 
(increase the probability) or weaken (decreasing the probability) of that action. 
While this criteria of selecting actions seem to be beneficial in discovering all 
actions effect, it introduces risk. So this criterion can be modified to schedule 
the action selection rather than based on probability, by starting with a proper 
action then build on it according to its reward. However, taking action reward 
into consideration requires to take its sequence into consideration, i.e. the reward 
value with time. This can be introduced in the reward evaluation formula as a 
multiplication sequence factor. Evaluating the reward in this form enables the
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evaluation of the patient’s status with time, which could be a good indicator of 
the progress either in treatment plan.
7.3 ICP Patterns and Patient types
Shunt removal trials [16, 17] showed that intracranial hydrocephalus dynamics re­
spond to a programmable closure of the valve in almost different ways. These ICP 
patterns were classified into four common types, as shown in Figure 7.2.
#
Type 4 
(8 patients)/
■^Type 3 
(6 patients)
Type 2 
(3 patients)
Type 1
(4 patients)
Figure 7.2: Common ICP patterns of hydrocephalus patients after closure of
the multipurpose valve [17]
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• First ICP pattern: With the closure of the valve, the ICP remains within the 
normal range. According to this behaviour of the ICP, the patients having 
this pattern are clear to be easily weaned off the shunt and the patients 
can live without shunt. In this case the patient’s natural drainage system 
can be reactivated and the weaning process can be performed gradually to 
eventually lead to complete shunt removal. Takahashi [16] in his trial, showed 
that this pattern can be weaned without any complications.
• Second ICP pattern: The ICP in this pattern is increased and stabilised [17] 
at a higher value after valve closure. This higher value is above the normal 
range of the ICP. The higher value of the ICP is accompanied by symptoms 
and inflation in the intracranial ventricles. This type of ICP patterns indicate 
the types of patients which are partially dependent on the shunt. For this 
type of patients, there is a good chance to wean off the shunt as Takahashi 
reported in his study, but accompanied with risk.
• Third ICP pattern: The ICP in this case keep increasing when valve closed. 
The value of the ICP could reach a high value which could put the patient 
at risk. Identifying this case helps in avoiding those patients any risk when 
applying shunt removal process.
• Fourth ICP pattern: In this case, the ICP increases dramatically, to reach 
higher values in a short time. This type of patients is fully dependent on the 
shunt. Exposing those patients to weaning process without talking careful 
detection could lead to dangerous results and put patients at risk.
Capturing the shunt dependency by identifying the ICP pattern is the important 
task of the shunt performing weaning plan. This could be achieved by the intel­
ligent shunt which could monitor the ICP. The intelligent shunt performs more
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accurate and efficient measures of the dependency by evaluating other related pa­
rameters such as the CSF absorption and production ratio which could give an 
accurate figure of the actual shunt dependency.
7.4 Proposed Shunt Removal Approach 
- The Intelligent Shunt Idea
The proposed shunt technique is developed based on an intelligent agent system. 
This system mainly consists of two subsystems. The first subsystem is to manage 
the current situation of the ICP on the short run and to keep it within normal 
ranges under certain conditions and restrictions. The second subsystem is to pur­
sue a weaning plan in the long term. In this subsystem and based on the original 
Actor-Critic method, a new modified method of reinforcement learning is pro­
posed. This method uses a Simulink™ model of ICP dynamics that personalises 
and optimises model’s parameters according to specific patient’s data by learn­
ing from his/her ICP traces. These parameters are used to estimate the CSF 
production and absorption volumes.
Therefore, this approach implements a new shunting technique that could accu­
rately use an intelligent agent to optimise parameters of ICP dynamics model and 
then use it to satisfy the patient while evaluating shunt dependency and treatment 
plan.
The intelligent shunt pursues two aims at the same time. One of these is a short 
term aim which keeps the ICP within the normal levels. The other aim is a long run 
term to stimulate the normal absorption pathways, preparing for shunt weaning
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in cases showing successful compliance. The two aims are achieved by two mutual 
systems, closed-loop system and on-line learning and controlling system as shown 
in Figure 7.3. The intelligent shunt agent algorithm was built using a modified 
version of the Actor-Critic method and this is illustrated in Section 7.4.2.
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Figure 7.3: System overview.
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7.4.1 The Closed-loop System
The closed loop system has a microcontroller that perceives the ICP through an 
ICP sensor and controls an electronic valve (eValve), as shown in Figure 7.4. The 
electronic valve is regulated to open at a specific pressure value determined by the 
micro controller.
The microcontroller determines the current opening pressure of the valve based 
on two factors as indicated in Expression 7.5 (expression 2 in Figure 7.7):
1. Opening pressure setting ICPopen which is proposed by the policy “treatment 
plan” of the learning system, which is initialised to the normal range of the 
ICP which in average of lOmmHg. This initialisation of the valve is indicated 
in Expression 7.4 (expression 1 in Figure 7.7).
2. The instantaneous ICP which is sensed by pressure sensor ICPinst.
Initialise ICPoperi to normal ICP value (7.4)
Opening valve if ICPinst > ICPtopen (7.5)
In the current time, the valve opens if the instantaneous ICP value is above the 
suggested minimum opening pressure ICPinst. By this the valve satisfies the pa­
tient by draining the excessive CSF while following a certain policy to wean the 
patient off the shunt fulfilled by the online learning system in the microcontroller.
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Figure 7.4: Closed loop system part of intelligent shunting system
At the same time, the intelligent shunting keeps recording of a period T of ICP 
values and shunt opening period Tqn during the recording period as indicated 
in Expressions 7.6 and 7.7 (expression 3 and 4 in Figure 7.7). The ICP recorded 
during the period T is sampled with /s, which chosen in this system to be lOOKHz, 
similar to the sampling frequency used in diagnosis stage. The recording period 
T is chosen to be 1 hour as this is for the simulation purposes, this could vary 
according to the memory capacity of the microcontroller.
Recording UT” period of ICP with sampling frequency “fa” (7.6)
Recording opening period “Ton' (7.7)
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7.4.2 The On-line Learning and Controlling System
The on-line learning and controlling system is a system that learns from the pa­
tient’s direct data and then uses this to control the valve based on a specific 
weaning plan. This system has two main functions: The estimating value function 
and the policy function, as shown in Figure 7.5.
On-Line Learning and 
Controlling System
Reward
(CSFa.CSFp.lCPmean)
ICR
recorded 
in intervals
(Treatment plan)
Value
Function
Micro­
controller
ICR model 
optimising 
patient’s 
model 
parameters 
based on 
ICR traces
Figure 7.5: On-line learning and controlling system part of intelligent shunting
system.
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7.4.2.1 The Estimating Value Function
The estimating valve function is known as the Critic, it optimises an ICP dynamics 
model using the traces of the ICP during period T which is one hour in this simula­
tion. Then it estimates the absorbed (CSFr), drained (CSFc/) and produced (CSFP) 
cerebrospinal fluid flow rate based on measured mean ICP (ICPmeon) parameters 
as indicated in Expression 7.8 (expression 5 in Figure 7.7). After estimating pa­
rameters of N number of T intervals, the Critic evaluates a Figure of Merit (FoM) 
of the current state of the patient. The FoM determines whether things have gone 
better or worse than expected by evaluating its value by the learning system , The 
evaluating function of the FoM is indicated by Expression (7.9) (expression 6 in 
Figure 7.7). It calculates the FoM by evaluating the ratio of the CSF absorbed 
to the CSF produced for every T interval, and scaling each value by the sequence 
of the T interval. This scaling is to give the most recent ratios more weight and 
significance than the older ratios. The sequence scaling in this case indicates the 
compliance and progress of the patient’s state according to time. To keep the FoM 
in the range of 0-1, it is normalised by a factor 7 as indicated in Expression (7.9). 
FoM closes to 1 indicates a good response in the the natural absorption path­
ways as that the absorbed CSF flow rate CSFr equals the produced CSF flow rate 
CSFP, while FoM closes to 0 indicates poor functionality in the natural absorption 
pathways. The m and k in Expression 7.9 indicate the sequence number of the 
evaluation of CSFa and CSFP) and the FoM, respectively, this is illustrated in 
Figure 7.6.
Estimate CSFa, CSFP and CSFd based on measured ICPmean (7-8)
Chapter 7. Intelligent Shunt for Reducing Shunt Dependency 132
FoMk «— where 7 = —^------ (7.9)
<=1 k=2
m=1 m=2 m=3 I*" I m=N m=1 m=2 | m=3 |—| m=Nt t t
CSFai CSFa2 CSFaN
CSFP1 CSFp,
Figure 7.6: Time sequence of the evaluation of CSFa, CSFP and the FoM.
7.4.2.2 The Policy Function
The policy function is known as the Actor, represented in (expression 7 in Fig­
ure 7.7). It implements a treatment plan which chooses the next minimum opening 
pressure /CP0pe„fc+1 for the valve by modifying and scaling the current ICP open­
ing pressure ICPopenk. The next opening pressure of the valve is chosen based 
on the patient’s response in the current stage, which is evaluated by the FoM as 
indicated in Section 7.4.2.1. The patient shows a good response if the current 
value of the FoM is increased relative to its previous value, while bad response 
is indicated by a decreasing FoM. If the patient shows a good response then the 
valve opening pressure is increased, while bad response causes the valve opening 
pressure to be decreased. This dynamical behaviour of the shunt causes the shunt 
to respond to the CSF circulation system progress. The modified functionality of 
the Actor is indicated in Equation 7.10.
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ICP,openfc+,
Ga * ICPopenk , if FoMk > FoMk-i
Ot2 ' ICPopenk , if FoMk < FoMk-i
(7.10)
Where ai > 1 and a2 <
(1) Initialise ICPopen to normal ICP value 
o Repeat (for each N time of T period):
• Repeat (for each T period):
• Repeat (for each second T):
(2) - Opening valve if ICPinst >ICPopen
(3) - Recording “T period of ICP with
sampling frequency %”
(4) - Recording opening period “T0N”
• (5) Estimate CSFa, CSFP and CSFd based
on measured ICP mean
(6) FoMk <- y^ where Y =
Im=im
• (7) ICPopenk+1
J ^ • lCPopenk if FoMk > FoMk_x 
\cc2-lCPovenk if FoMk< FoMk_r
Closed-loop 
^ system
J
}
Learning system; 
b) Critic function
}
 Learning system; 
a) Actor function
Figure 7.7: Intelligent Shunt Algorithm.
7.5 Modelling the Change in the Patients’ Nat­
ural Drainage System
Modelling the behaviour of the natural drainage system is necessary to test and 
evaluate the intelligent shunt system and the weaning process. Where the natural
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drainage pathways are believed to occur through different pathways, it can be 
modelled as a single resistance, as shown in Figure 7.8.
Volume ofFlow rate of
absorbed CSFabsorbed CSF
IntegrationReabsorption 
of CSFPatient type simulation
CSF
absorption
Resistance
Figure 7.8: Modelling the normal absorption pathways. The relation between 
the ICP, absorption resistance and the flow rate of the absorbed CSF.
A different formulas relating the change in the natural drainage system resistance 
to the change in the intracranial pressure through the period of the shunt removal 
procedure is presumed to simulate different patients’ scenarios and their response 
to shunt closure based on patients’ types explained by Longatti [17] as in Fig­
ure 7.2. Hypothetical scenarios are presumed representing different levels of shunt 
dependency in the “Patient type simulation” in Figure 7.8. The natural absorp­
tion resistance {Rabsorption) is varied according to the ICP and time sequence of 
shunt removal procedure.
To represent a a shunt dependent patient the natural absorption resistance (Rabsorption) 
is simulated to vary with respect to the ICP and the time sequence in the weaning 
period in an exponential increasing as in Equation (7.11),
Rabsorption ki ■ expk2tICP (7.11)
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Hypothesised shunt independent patient is simulated with the natural absorption 
resistance (Rabaorption) is exponentially decreasing with the ICP and the time se­
quence, as indicated in Equation (7.12),
Rabaorption = ' exp k*-t'ICP (7.12)
Where is k\ represents the initial value of the natural absorption resistance and 
and k2 represents a scaling factor for the increasing and decreasing rate of the 
natural absorption resistance in the exponential function. Time (t) represents the 
time progress in the weaning procedure and (ICP) is the intracranial pressure. The 
ICP increasing represents the valve closure which stimulates the natural drainage 
pathways and in the case of shunt independent it decreases afterward while staying 
high in the case of shunt dependent.
Two cases of patient’s types according to shunt dependency level are simulated 
in this work. However, different cases can be simulated in the “Patient type 
simulation” block, as it is left for the intelligent shunt to “learn” patient’s status 
and adapt to his/her specific case.
7,6 Proposed Shunt Behaviour for Different Pa­
tients’ Scenarios
The Matlob Simulink™ ICP dynamics model explained in Chapter 5 is adopted 
in this work. This model is used in the Critic function part of the learning system
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to optimise and estimate the model’s parameters. After introducing the natural 
drainage system model as explained in Section 7.5 , the model is used as a simulator 
to simulate patient’s case scenarios.
The model is used as an optimiser, which takes the ICP traces of the patient’s 
CSF dynamics into intervals and optimises parameters of the model to reproduce 
ICP traces resembling the received one. The optimised parameters are the CSF 
absorbed, drained and produced flow rates. The usage of the model as a patient’s 
environment is to emulate the production of the ICP traces reflecting different 
scenarios, these scenarios govern the different cases of patient’s progress under 
shunt removal procedure, as reported in [17] and explained in Section 7.3, where 
four groups were noticed after applying shunt removal program for hydrocephalus 
patients. In the first group there is no change in the ICP after occluding the valve 
which means the patient is fully independent of the shunt, while in the second 
group ICP stabilised at high levels but without symptoms, in the third group the 
ICP exhibits high ICP after a period of time, while in the last group it exhibits 
dramatic increase in ICP immediately after valve occlusion, which shows total 
dependency on the shunt.
Two of these scenarios were implemented in the model which represents the pa­
tient’s environment, the fully shunt independent and fully shunt dependant,
The intelligent shunt agent algorithm was tested for both of these cases; the shunt 
independent (Figure 7.9) and shunt dependant (Figure 7.10). Figure 7.9(a) shows 
the simulation results of the first case where the patient is totally independent of 
the shunt and by exposing the CSF absorbtion pathways to a high ICP it stimulates 
and shows an enhancement in the normal drainage system, that is indicated by 
increasing FoM which shows progress while ICPmean is increasing obviously as
Chapter 7. Intelligent Shunt for Reducing Shunt Dependency 137
ICPopen increased. Figure 7.9(b) shows increasing absorbed CSF flow rate as the 
normal pathways enhanced with decreasing drained CSF flow rate through the 
shunt as minimum opening pressure for the shunt is increased. In the second 
case where the patient is highly dependent on the shunt, Figure 7.10(a) shows the 
response of the shunt agent to this case as it starts decreasing ICPopen resulting 
in a decrease in ICPmean as the FoM indicates a slight decrease which reflects 
weak or bad normal drainage system. Figure 7.10(a) shows that as a sequence 
of decreasing the opening pressure of the valve, the drained CSF flow rate is 
increased while the absorbed CSF flow rate is decreased. This case shows how bad 
the natural drainage system is
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Figure 7.9: Behaviour of shunt agent in case of patient independent of shunt, 
(a) ICPopcn and ICPmean annotated by FoM reward, (b) CSFa^or^ and
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Figure 7.10: Behaviour of shunt agent in case of patient highly dependent on 
shunt, (a) ICPopen and ICPmean annotated by FoM reward, (b) CSFabsorbed
and C SFdraincd
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7.7 Conclusions
Despite of many improvements in the differential pressure valves and the inven­
tion of the mechatronic valve, they still lack the flexibility in responding to the 
dynamical behaviour of the CSF due to simple mechanism of regulating the valve. 
This motivates the needs for a new method in controlling the valve to dynamically 
adapt to the patient’s needs. What is proposed in this work is a new approach 
of regulating the valve by an intelligent system which dynamically adapts to the 
patient’s needs. The intelligent shunt estimates the degree of shunt dependency 
and attempts to reduce shunt dependency over a period of time, which could be 
months or years, during this period careful attention is directed to the CSF ra­
tio (CSF absorbed to that produced), where CSF ratio is estimated at regular 
intervals by learning system. The criterion of successful treatment is determined 
by achieving high CSF ratio with high opening pressure of the shunt. In those 
patients in whom it is totally shunt dependent, the valve nevertheless is used in an 
attempt to keep the ICP within the normal levels. In this way shunt dependency 
is detected and weaning plan is attempted while the shunt is still performing its 
original function by keeping the ICP within the normal levels. Equipping the 
intelligent shunt with a learning system that helps in decision making regarding 
shunt removal plan whether to processed with the current plan or changing it has 
personalised and automated the weaning process.
Chapter 8
Conclusions
This work, proposes an optimiser system for the valve settings of the current shunts, 
a technique used to tackle one of the problems in the current shunts. Then the 
optimiser is upgraded to optimise the valve settings of the prospective shunts, 
which depends on a time schedule as a control signal. This new proposed valve, i.e. 
time schedule valve, is designed and developed to overcome some of the problems 
in the current passive shunts, but as it is a time-schedule driven valve, proper time 
schedule is still a changing issue for these types of shunt. Then these shunts are 
upgraded into higher further step by introducing intelligent system, that would 
autonomously managing and personalise treating hydrocephalus by incorporating 
ICP readings and posture angle.
A model of the intracranial hydrodynamics is developed to investigate and eval­
uate the proposed shunts technique. Furthermore, a new feature extracting and 
analysing method is implemented to analyse and classify hydrocephalus patients 
according to parameters extracted from the ICP signal and other patients’ informa­
tion. An optimisation algorithm was developed to help in proposing an optimum 
and patient specific valve settings for the current valves, based on each patient’s
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intracranial pressure signal and posture angle, which provides the physician and 
surgeon with a tool that facilitate the use of the passive mechatronic valves. Differ­
ent CSF parameters that characterise its formation and circulation and the valve 
parameters that control its behaviour were identified and studied. To investigate 
the relationship among the valve parameters, CSF circulation parameters and the 
ICP valve, an optimiser is implemented and modeled.
A new method was introduced to enable the intelligent shunt to evaluate and 
determine the actual shunt dependence. In addition, algorithm is developed and 
investigated to actively establish shunt independence (weaning the patient off the 
shunt). The behaviour of the shunt and the CSF circulation system were modeled 
and simulated to test the shunt dependence and weaning algorithm.
8.1 Conclusions
This work put forward the better utilising of the current shunt and the prospective 
new shunts. This requires the developing of a valve settings optimiser, that analyse 
the patients’ ICP readings and other data, and propose optimum shunt settings, 
specific for each patients.
Then this work proposed, simulated and modeled an autonomous shunting system 
for personalised hydrocephalus treatment. This implies the usage of a mechatronic 
valve, ICP pressure and posture angle sensors, and developing algorithm to analyse 
the ICP data and posture angle, optimiser to estimate other relevant parameters, 
and an intelligent learning system for decision control.
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The intelligent system agent in the shunt can autonomously manage intracranial 
pressure and monitor the hydrocephalus treatment process by evaluating the CSF 
circulation response based on action taken by the agent controlling the valve. This 
innovation in shunting system gives the opportunity for the hydrocephalus patients 
to not just have the ICP managed but also gives the possibility of treating hydro­
cephalus by applying certain careful controlling actions on the valve, according to 
this surgical interventions and hospital reversions will be minimised.
Despite of the progress in the passive valves in managing hydrocephalus, they 
still lack to a clear standard procedure of proposing their settings, adding to 
that their inherited shortcoming in managing hydrocephalus. All these initiate 
the motivation to upgrade this mechanical valve to a mechatronic valve, while 
investigating the ways that the mechatronic valve could be controlled, put the 
needs for more intelligent rather than just simple control. The results showed that 
the settings optimiser for both the passive and time-scheduled shunts achieved 
good results in managing the intracranial pressure within the normal ranges, where 
the later option, takes useful of the flexibility of dynamically controlling the valve 
through the changing of the time schedule and relating that to both the ICP level 
and the posture angle sensory inputs, by adjusting the on/off periods of the valve 
to suit the patients needs.
Nevertheless, with this flexibility for the mechatronic valve with time-schedule, it 
still lacks the intelligence in evaluating patients status and initiating a long run 
treatment rather than just depends on short term in keeping ICP within the normal 
levels. As a result, integrating the mechatronic valve with ICP and posture angle 
sensors, driven by intelligent learning agent would give more effective solution.
For the mechatronic valve to work properly, its schedule time should be selected
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carefully. The proposed optimiser would help in developing the proper and opti­
mum schedule for patient in specific, that dynamically change based on the patients 
intracranial pressure data and posture angle, which providing the physician with 
a good tool that help in preparing the valve with an initial schedule. The resul­
tant intracranial pressure for the proposed schedule of the simulated mechatronic 
valve shows the effectiveness of the optimiser in proposing schedule that suit each 
patient which maintain the ICP within the normal range.
The parameters used for optimising the schedule along with other parameters that 
can be extracted from the optimising the ICP model can be used for controlling 
the mechatronic valve online. It has been shown that the using of ICP, posture 
angle and CSF production and absorption parameters, which extracted from the 
model as the evaluation parameters for the performance of the intelligent agent 
is effective, as ICP ad posture give indication for short run term by keeping the 
ICP within the normal levels, and CSF production and absorption give indication 
of the shunt weaning progress in the long run term and the treatment process. 
These parameters enable the mechatronic shunt agent to autonomously person­
alise the management of hydrocephalus. The proposed intelligent shunting agent 
relieved the worry about shunt removal as it will implement a machine learning 
algorithm that would personalise the management and treatment plan to suit in­
dividual patients needs, while it pursues two gaols at the same time, satisfying the 
patient in the current time by maintaining ICP within normal limits and long run 
by evaluating the patient ability of shunt removal and initiating a plan targeting 
the stimulation of the normal drainage pathways. This would ease the physician 
concern about shunt removal. As the simulation results show, the actor critic algo­
rithm after modification is proposed to be the learning algorithm in the intelligent 
shunt agent to continually manage the ICP and initiate a weaning process.
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The proposed techniques in this work presented different solutions tackling the 
hydrocephalus problem from more than one side. First, a new analysis method of 
the ICP data and patients information were proposed and implemented showing 
the suitability of method in extracting useful features from the patients ICP and 
other data. Second, enhancing the performance of the current shunts by optimising 
their settings, tailored to patient in specific, this satisfies patients’ needs and 
reduce hospital visits and shunt revisions. Third, giving the opportunity of start 
utilising the time-schedule shunts by proposing a new method which incorporate 
an optimise!* which proposes an optimum time schedule for these shunts. Fourth, 
proposing a new shunt system which integrate intelligence int he mechatronic 
valve, this differs from the current shunt in that it is monitoring the patient’s ICP 
and other data continually, which enable the agent to monitor and diagnose the 
patient’s status based on parameters extracted from the CSF circulation model.
8.2 Possible Development and Enhancement
Future work is expected in the first aspect which is the analysis of the ICP data 
according to the proposed method, to incorporate time series of the patients’ ICP 
traces along with more annotated status data. This may enable to follow-up 
patient’s according to their status. At that point another classification technique 
could be used to classify patients’ status, which may give the ability to control 
certain parameters that force the patient’s status to go in certain direction, so this 
more work would be a good tool wither in hydrocephalus diagnoses or prognoses.
Suggested work in the shunt settings optimiser either in passive or time-schedule 
valves can incorporate more parameters and when enough data available more
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simulation is expected. Transferring these proposed optimisers to the clinic and 
implementing them in the real cases would be encouraging as these are imple­
mented offline before shunt installation, which gives the surgeon the opportunity 
of judging the optimum settings proposed by the optimiser before going on with 
shunt implantation.
Future enhancement in the intelligent should incorporate more parameters in eval­
uating patient’s status either in the long or short term. This would enhance the 
performance of the shunt. Adding to that, shunt blockage which is one of the shut 
problems, can be detected with intelligent shunt ability, thus avoiding patients 
from associated problems. Adding a telemetry system to this intelligent shunt can 
add significance to this work, where data mining and knowledge acquisition are 
employed and enabling the physician for any intervention.
Safety concern in utilising the intelligent shunt, however should be investigated 
more. This can be implemented by connecting the intelligent shunt to a telemetry 
device where regular readings of the ICP and the valve actions could be reported 
to a central database where the surgeon and physician have a supervision of it
behaviour.
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Figure 1: A Modified Simulink of hydrocephalus ICP dynamic model [76]. 
Consists of five volumes (arterial, brain, capillary, CSF and venous).
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Figure 2: Intracranial pressure block [76].
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Figure 3: Changing in intracranial pressure from changing in posture an­
gle [76].
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Figure 4: Indicated blood flow [76].
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Figure 5: Capillary resistance [76].
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Figure 9: Arterial resistance [76].
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Figure 10: The affect of the posture angle on the arterial blood [76].
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Figure 11: The affect of the posture angle on the venous blood [76].
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Figure 12: The arterial redias [76].
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Figure 13: The normal absorption pathways [76].
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Figure 14: The capillary to venous flow [76].
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Figure 15: The blood flow [76].
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Figure 16: The closed loop shunt [76].
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Figure 17: Behaviour of shunt agent in case of patient independent of shunt, 
(a) ICPopen and ICPmean annotated by FoM reward, (b) CSFabsorbe(i and
CSFdrained
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Figure 18: Behaviour of shunt agent in case of patient highly dependent on 
shunt, (a) ICPopen and ICPmean annotated by FoM reward, (b) CSFabsorfod
and CSFdrained
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ICP_real trace (Observed) 
ICP_modulated (Estimated)
Time (minutes)
Figure 19: Characterisation of the patient model, and the actual mean 
ICP is 15.8 mmHg and the modulated mean is 16.2 mmHg
ICP_Normal level (Recommended) 
ICP_modulated (Generated)
Time (minutes)
Figure 20: Characterisation of the patient model, and the actual mean 
ICP is 15.8 mmHg and the modulated mean is 16.2 mmHg
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IGP Normal level (Recommended) 
>ctfjnodulated (Generated)
Time (minutes)
Figure 21: Optimisation of shunt opening pressure with fixed resistance 
value, Pth = 14.9mmHg for Rv= 6mmHg/ml/min, and the 
resultant mean ICP is 12.3mmHg
ICP_Normal level (Recommended) 
ICP_modulated (Generated)
Time (minutes)
Figure 22: Optimisation of shunt resistance with fixed opening pressure 
value, Rv= 33.5mmHg/ml/min for Pth = OmmHg, and the 
resultant mean ICP is 10.5mmHg
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,P_Normal level (Recommended) 
T_modulated (Generated)
Time (minutes)
Figure 23: Optimisation of shunt opening pressure with fixed resistance 
value, Pth = 13.2mmHg for Rv= lOmmHg/ml/min, and the 
resultant mean ICP is 11.3mmHg
ICP_Normal level (Recommended) 
ICP modulated (Generated)
Time (minutes)
Figure 24: Optimisation of shunt resistance with fixed opening pressure 
value, Rv— 27.7mmHg/ml/min for Pth = 4.5mmHg, and the 
resultant mean ICP is 10.6mmHg
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ICP before shunting 
ICP modeled
-10 -
Time (hours)
Figure 25: Characterisation of the patient model, and the actual mean 
ICP is 15.8 mmHg and the modulated mean is 16.2 mmHg
ICP before shunting mean value 
— ■ ICP modeled after shunting lower limit - 
—— ICP modeled after shunting upper limit
-10 -
Time (hours)
Figure 26: Optimisation of shunt opening pressure with fixed resistance 
value, = 14.9mmHg for Rv= 6mmHg/ml/min, and the 
resultant mean ICP is 12.3mmHg
D
ut
y 
cy
de
 %
 
Du
ty
 c
yc
le
 %
Appendix E. Time scheduled Valve Optimiser 188
Duty cycle vs mean ICP observed 
Best linear fitting y = 0.72*x - 2.1
•• •
ICP observed (mmHg)
Figure 27: Optimisation of shunt resistance with fixed opening pressure 
value, Rv= 33.5mmHg/ml/min for Pth = OmrnHg, and the 
resultant mean ICP is 10.5mmHg
• Duty_cyde vs Body_angle 
—Best linear fitting y = - 0.41*x + 25
Posture angle (degree)
Figure 28: Optimisation of shunt opening pressure with fixed resistance 
value, Pth = 13.2mmHg for Rv= lOmmHg/ml/min, and the 
resultant mean ICP is 11.3mmHg
Appendix F 
PC A Analysis
189
C
om
po
ne
nt
 
c 
2 Com
po
ne
nt
Appendix F. PC A Analysis 190
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Katz FD
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Peak Power
Non-Linear Energy
(eak Fre quency
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re 29: ICP features represented in the first and second component of the
PCA plane
Non-Linear Energy
Shannon Entropy
Hurst Paii ameterpeak Power
Katz FD
Curve Length
Peak FreiSpectral Entropy quency
3 Component
Figure 30: ICP features represented in the third and fourth component of the
PCA plane
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Energy
//Mean
Katz FD
Spectral EntropylurstParameter.
Peak Power
Non-Linear Energy
Peak * K' 
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Cfus er
Cluster
three -
1st Component
le 31: Analysis of the patients represented in the first and second com­
ponents of the PC A plane, showing three clusters of patient types
Non-Lin ar Energy
.Shannon Entropy
lurst Parai Peak Rower
'eak F requency • Spectral Entropy
1 Component
Figure 32: The three clusters as shown from the first and fourth components
of the PCA
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Energy
Mean
Curve l.ength
Spectral Entropyirameter
ak Power
Non-Linear Energy :
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1st Component
33: Age as a supplementary variable is projected on the first and 
second components of the PCA plane
Non-Linear Energy
Shannon Entropy
Katz FD Gender
Mean
Curve Length
Spectral Entropy Peak Frequency
3 Component
Figure 34: Gender as a supplementary variable is projected on the third and 
fourth components of the PCA plane
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Table 1: Extracted ICP Features.
Feature Equation
Mean Xi
Curve Length £ 'E'i •X-'i—l
Energy E x?
Nonlinear Energy E -xi.xj 2+a:|i
Katz FD log(h—V)
log'^&^i=^±£l+l0g(k 1) 
SiV'<"i+l-i)S+i
Hurst In (v <7x(x) 2/
Shannon Entropy -E f(x).log(f(x))
Peak Power max(PSD)
Peak Frequency index(max(PSD))
Spectral Entropy -E PSD.log(PSD)
